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ABSTRACT 
The prevalence of neurodegenerative disease is projected to increase in 
proportion to the doubling of older Americans over the coming decades. While age is 
the principle epidemiologic factor, it is likely that the development of these complex 
neuropathological entities is multifactorial and reflects the accumulation of chemical, 
physical and/or biological insults to the CNS. The Superfund chemical, 1,3-
Dinitrobenzene (DNB), is an industrial intermediate in the production of dyes, plastics, 
and explosives. DNB selectively targets astrocytes in brainstem nuclei innervated by the 
8th cranial nerve. The toxicity of DNB has been previously linked to dysfunction in 
astrocyte mitochondria. This study focuses on the susceptibility of key astrocytic 
mitochondrial proteins to selective and specific oxidation following exposure to DNB in 
vitro and in vivo.  Using an immortalized cortical astrocyte culture, passage number 
provided a useful surrogate for age in vitro. In a co-culture system containing 
immortalized astrocytes and primary neurons, low passage immortalized astrocytes are 
able to protect neurons in DNB exposure (whereas high passage immortalized 
astrocytes are not); additionally, low passage immortalized astrocytes are better able to 
survive DNB exposure in co-culture than high passage immortalized astrocytes. 
Additionally, in vivo data shows that proteins in older mitochondria are more susceptible 
to oxidation by DNB than the ones from young organelles, and mitochondria-related 
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proteins are more highly expressed in young control animals than in older animals (both 
control and DNB-exposed).  This data suggests that aging increases 
mitochondrial susceptibility to DNB-induced neurotoxicity. Using a high throughput 
proteomic approach with subsequent pathway analysis, it was determined that cation 
transmembrane transporter, nucleoside-triphosphatase, pyrophosphatase, and 
hydrolase activity pathways are selectively vulnerable to oxidation in older mitochondria.  
These results provide compelling evidence that environmental chemicals such as DNB 
may aid in the acceleration of injury to specific brain regions by inducing oxidation of 
sensitive mitochondrial proteins.   
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CHAPTER I 
 
INTRODUCTION 
 
 
 
Public Health Significance 
 As of 2010, 40 million Americans were over the age of 65 (representing 13% of 
the total population) (1). This number is expected to grow to 87 million by the year 2050 
(1).  Age is a major risk factor for a number of neurodegenerative diseases, including 
Parkinson’s Disease (2),  Alzheimer’s Disease (3), and dementia (4) [of which 65% is 
caused by Alzheimer’s Disease in those 65 years and older (5)].  The prevalence of 
neurodegenerative disease will likely rise as the number of older Americans doubles 
over the coming decades.  This presents a significant public health problem for the 
following reasons:  1) survival for those diagnosed with neurodegenerative diseases is 
11.7 years in patients diagnosed with dementia at 65 years of age (6); 2) care for those 
with neurodegenerative disease is expensive; and 3) there are currently no cures for 
neurodegenerative diseases.   
 The development of neuropathic states over time involves multiple contributing 
and causative factors.  Thus, understanding the differences between healthy brain 
aging and the accumulation of neural damage over the life course of the individual 
(including exposures to environmental contaminants) will aid in the identification of 
critical tipping points in the process of neurodegeneration.   
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Cellular and Mitochondrial “Aging” and Neural Susceptibility 
 Although astrocytes can retain the ability to replicate throughout the lifespan, 
neurons are post-mitotic.  New neurons and astrocytes can, however, arise from neural 
progenitor cells (NPCs) in the adult mammalian brain (7).  These multipotent NPC 
populations are spatially restricted to the subgranular layer of the dentate gyrus in the 
hippocampus and the subventricular zone of the lateral ventricles (8).  Because most 
regions of the brain do not contain NPCs from which new neurons may arise, the age of 
neurons between different regions of the adult brain may differ.  Therefore, the 
biochemical demands on astrocytes in these regions may differ as a result.  
Additionally, aging causes a significant decrease in neuronal progenitor proliferation and 
in migration of new neurons in adult rat hippocampus (9).  Aging of a cell, therefore, not 
only refers to an accumulation of functional changes in astrocytic daughter cells, but 
also to the accumulation of functional changes in postmitotic neurons and the 
multipotent NPCs from which new astrocytes and neurons may be derived.       
 The accumulation of posttranslational modifications to proteins, such as 
oxidation, can, over time, result in alterations in structure and function.  During the aging 
process, astrocyte populations amass functional changes to proteins in multiple 
pathways that are detrimental to their ability to perform neuroprotective functions, 
including increased expression of mutant huntingtin in mice (10).  Additionally, because 
neurons don’t replicate, the neurons that persist postnatally through adulthood accrue 
damaging posttranslational modifications, such as oxidation (11), (12), (13) (14).  
Therefore, astrocytes must accommodate the “aged” neuronal environment in adult 
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mammals, when they themselves are at a higher risk for dysfunction as a result of the 
aging process. 
 As mammals get older, mitochondria have a propensity to accumulate damage 
(oxidized proteins (15), mutated mtDNA (16), (17), etc.), which is often colloquially 
referred to as mitochondrial aging.  However, mitochondrial “aging” within the brain is a 
complex and dynamic process; these organelles have the ability to fuse together 
(fusion), and to split from one mitochondrion into two distinct mitochondria (fission).  
Mitochondria undergo these fusion and fission events in response to the immediate 
cellular microenvironment.  Mitochondrial fission events segregate mitochondrial 
contents (mtDNA, electron transport chain (ETC) enzymes, antioxidants, reactive 
oxygen species (ROS), etc.) into two distinct mitochondria.  Mitochondrial fusion events, 
conversely, mix these contents from two mitochondria into one mitochondrion.  Although 
mitochondrial fusion and fission is dynamic, these events aren’t stochastic.  As a 
function of age in culture, fusion events decreased as fission rates increased in 
rotenone-exposed rat primary cortical neurons; the opposite was true in control primary 
neurons (18).  Fusion events, followed by near immediate fission of the previously fused 
mitochondrion, also increased in frequency in rotenone-exposed rat primary cortical 
neurons (18).  Therefore, not only can mitochondrial fusion and fission events be linked, 
age in culture also influences the frequency and type of mitochondrial dynamic events.   
 Mitochondrial remodeling processes occur throughout the life course.  However, 
when mitochondria are significantly damaged, they are eliminated via autophagy or can 
be segregated from the remaining mitochondrial population by fusing with an adjacent 
healthy mitochondrion (19).  Autophagous processes themselves decline in efficiency 
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with age (20), increasing the risk of the accumulation of damaged mitochondria in a 
time-dependent manner.  It is crucial that damaged mitochondria are appropriately 
removed from cells; this is crucial not just for the health of the aging individual, but their 
offspring as well.  Recently, it was discovered that maternally transmitted mtDNA 
mutations in mice can induce aging phenotypes and abnormal brain development in 
offspring mice (21). 
 
Environmental Exposure to Neurotoxicants during Aging  
 Age is a primary risk factor for the development of neurodegenerative disease.  
However, due to the unknown etiology of most late-onset neurodegenerative diseases, 
exposures to neurotoxicants over the life course have been postulated to play a role.  
Causal determinations between environmental exposures (both discrete exposures and 
chronic exposures) and development of neurodegenerative diseases in humans have 
proven difficult to achieve.  The most convincing evidence of associations between 
exposures and onset of neurodegenerative diseases have come from occupational 
exposures to heavy metals in humans; mechanistic data investigating these links in 
laboratory animals have provided some insight, and likely include disruption of iron 
and/or zinc homeostasis  (reviewed by Cannon and Greenamyre) (22).  Altogether, the 
exact mechanisms by which environmental exposures cause or contribute to the 
development of neurodegenerative disease have remained elusive.  
 Occupational exposure to manganese in welders is one of the most well studied 
exposures attempting to establish neurotoxicants in the etiology of neurodegenerative 
diseases.  There is also a need for characterizing environmental exposure to 
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manganese as a contributor to neurotoxicity across the life course, in addition to what is 
known of occupational exposures (23).  Manganese exposure causes an array of 
neuromuscular symptoms, many of which overlap with parkinsonism (24) (also referred 
to as idiopathic Parkinson’s Disease in the literature). Epidemiologic studies have linked 
advanced age and occupational exposure to manganese with poorer performance in 
neurobehavioral tests than age-matched controls (25).  The mechanism of manganese 
neurotoxicity has been explored in developing, adult, and aged rats: in neonatal rats, 
manganese exposure caused an increase in dopamine and norepinephrine, whereas in 
adult rats, it caused a decrease in dopamine (26); in brainstem of aged rats, chronic 
manganese exposure depleted noradrenaline, dopamine, and glutathione levels, while 
increasing amino acid oxidation (27).  This data suggests that older rats are more 
susceptible to the neurotoxic effects of manganese exposure, including oxidative stress 
in the brainstem.  This increased susceptibility due to age is also likely to be true for 
other neurotoxicants that cause oxidative stress, including 1,3-Dinitrobenzene (DNB).    
   
1,3-Dinitrobenzene-Induced Regional and Cellular Susceptibility in Brain 
 1,3-Dinitrobenzene (DNB), a Superfund chemical, is an industrial intermediate 
used in the production of dyes, explosives, and plastics.  In humans, DNB exposure 
causes ataxia, dizziness, and nausea.  In rats, DNB exposure causes 
methemoglobinemia and ataxia, with bilaterally symmetrical spongiform lesions evident 
in areas of the brainstem innervated by the 8th cranial nerve (28).  In vivo, initial cellular 
targets of DNB exposure include glia (astrocytes, oligodendrocytes) and the 
vasculature, followed by involvement of neurons (28).  Because DNB-induced lesions 
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closely resemble those observed in acute energy deprivation syndromes, it was 
hypothesized that the mechanism of toxicity of DNB in the glia of the brainstem involved 
a disruption of mitochondrial function, likely involving a disturbance in redox balance 
within the mitochondria (28).   
Cellular Susceptibility  
 Exposure to DNB causes differential mitochondrial sensitivity in cultured neurons 
compared to astrocytes.  Neuroblastoma cells (SY5Y) exposed to DNB exhibited 
mitochondrial reduction potential nearly ten times lower than that of DNB-exposed C6 
glioma cells, while inducing the mitochondrial permeability transition (MPT) in both C6 
and SY5Y cells (29).  Additionally, DNB exposure inhibits the pyruvate dehydrogenase 
complex in C6 glioma cells (30).  Mitochondrial permeability transition pore (mtPTP)-
induced cell death is governed by a specific group of proteins, including Bcl-XL, Bcl-2, 
and Bax. C6 glioma cells express significantly more Bcl-XL than SY5Y cells exposed to 
DNB, while conversely, SY5Y neuroblastoma cells expressed significantly higher levels 
of Bcl-2 and Bax compared to C6 cells (29).  These data suggest that a compromise of 
the mitochondrial membrane potential plays a role in the differential susceptibility to 
DNB in neurons and astrocytes.    
DNB exposure causes increased production of ROS and loss of mitochondrial 
membrane potential in immortalized astrocytes, while at the same time producing 
distinct carbonylation profiles of organellar proteomes (namely mitochondrial) (31).  This 
indicates that while DNB induces higher ROS production within the cell overall, specific 
carbonylation of mitochondrial proteins in astrocytes may ultimately affect their 
neuroprotective capability and contribute to the mechanism of toxicity of DNB.  
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Regional Susceptibility 
   Region-specific investigations of mitochondrial function within brainstem and 
cortex in DNB exposure provide evidence of a change in Bcl-XL expression in cortical 
astrocytes, but not brainstem astrocytes (32).  Additionally, DNB exposure inhibits 
mitochondrial succinate dehydrogenase activity in both brainstem and cortical 
astrocytes; this inhibition was prevented by mtPTP inhibitors bongkrekic acid and 
cyclosporin A in brainstem astrocytes only (33).  This evidence supports the premise 
that regional susceptibility is specific to opening of the mtPTP.  Opening of the mtPTP 
can be caused by increases in ROS.  Increases in DNB-induced ROS in brainstem 
mitochondria, as measured by specific carbonylated mitochondrial proteins, have been 
shown (Dr. Stephen Steiner, unpublished data).   
 
Research Gaps to be Addressed by this Dissertation 
       It has been established that damage to macromolecules accumulates during aging, 
and that there is considerable cellular and regional variability in the brain regarding 
susceptibility to these accumulations.  Mechanisms with which oxidative damage to 
proteins is removed and antioxidant stores are replenished attenuate in the brain over 
time.  DNB exposure results in regionally-confined lesions, with specific cellular targets 
within those regions.  DNB causes decreases in selected enzymatic functions in 
astrocyte mitochondria, increases in proteomic oxidation in immortalized astrocyte 
mitochondria, and shifts in mtPTP dynamics in brainstem and cortical mitochondria.  
Exposure to environmental neurotoxicants, such as DNB, can exacerbate the limits to 
which the aging brain can efficiently respond.  
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 Therefore, it is hypothesized that (Figure 1.1):  
Aging increases mitochondrial susceptibility to neurotoxicity induced by 1,3-DNB 
by causing mitochondrial membrane instability in astrocytes, oxidation of 
specific pathways in mitochondria-related proteins in brainstem, and altering 
expression profiles of mitochondria-related proteins. 
 
 
Specific Aim 1) Stability of mitochondrial membrane potential confers 
susceptibility to 1,3-DNB toxicity 
 
Specific Aim 2) Determine whether or not the degree of 1,3-DNB-induced 
oxidation of MRPs in susceptible brainstem regions is dependent on age 
 
Specific Aim 3) Determine whether or not there are differences in compensatory 
molecular pathways between younger and older brainstem mitochondria in 1,3-
DNB exposure 
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Figure 1.1 Age-Related Vulnerability to DNB-Induced Neurotoxicity 
Exposure to DNB causes spongiform lesions in the brainstem in old animals, with increased vacuolation 
of the neuropil.  Because mitochondria accumulate damage over time during the aging process, 
mitochondria related proteins (MRP) within the brainstem of older animals are more vulnerable to DNB-
induced damage than younger animals.  Brainstem astrocytes are a cellular target of DNB; in vitro, low 
passage co-cultured astrocytes were better able to survive DNB exposure compared to high passage co-
cultured astrocytes, and were able to better perform neuroprotective functions, such as preventing 
neuronal depolarization.  Low passage co-cultured astrocytes exhibit lower intracellular ATP compared to 
high passage co-cultured astrocytes, indicating that low passage astrocytes may release more ATP into 
the extracellular space (which can be dephosphorylated to adenosine) and therefore can better silence 
neurons compared to high passage co-cultured astrocytes in response to DNB exposure.  Because DNB 
inhibits adenosine deaminase (Wang, et al. 2012), DNB itself directly contributes to the prevention of the 
conversion of adenosine to inosine and may therefore contribute to an increase in extracellular 
adenosine. (N = Neuron, A = Astrocyte, V = Vasculature, Red Arrow = Vacuolation) 
  
10 
 
REFERENCES 
 
 
1. Statistics FIFoA-R. Older Americans 2012: Key Indicators of Well-Being. In: 
Statistics FIFoA-R, editor. Washington, D.C: U.S.: U.S. Government Printing 
Office; 2012. 
 
2. Moghal S, Rajput AH, D'Arcy C, Rajput R. Prevalence of movement disorders in 
elderly community residents. Neuroepidemiology. 1994;13(4):175-8. 
 
3. Lindsay J, Laurin D, Verreault R, Hebert R, Helliwell B, Hill GB, et al. Risk factors 
for Alzheimer's disease: a prospective analysis from the Canadian Study of 
Health and Aging. Am J Epidemiol. 2002;156(5):445-53. 
 
4. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, Dartigues JF, et 
al. Incidence of dementia and major subtypes in Europe: A collaborative study of 
population-based cohorts. Neurologic Diseases in the Elderly Research Group. 
Neurology. 2000;54(11 Suppl 5):S10-5. 
 
5. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, et al. 
Prevalence of dementia and major subtypes in Europe: A collaborative study of 
population-based cohorts. Neurologic Diseases in the Elderly Research Group. 
Neurology. 2000;54(11 Suppl 5):S4-9. 
 
6. Xie J, Brayne C, Matthews FE. Survival times in people with dementia: analysis 
from population based cohort study with 14 year follow-up. BMJ. 
2008;336(7638):258-62. PMCID: 2223023. 
 
7. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson 
DA, et al. Neurogenesis in the adult human hippocampus. Nat Med. 
1998;4(11):1313-7. 
 
8. Gage FH, Kempermann G, Palmer TD, Peterson DA, Ray J. Multipotent 
progenitor cells in the adult dentate gyrus. J Neurobiol. 1998;36(2):249-66. 
 
9. Kuhn HG, Dickinson-Anson H, Gage FH. Neurogenesis in the dentate gyrus of 
the adult rat: age-related decrease of neuronal progenitor proliferation. J 
Neurosci. 1996;16(6):2027-33. 
 
10. Bradford J, Shin JY, Roberts M, Wang CE, Li XJ, Li S. Expression of mutant 
huntingtin in mouse brain astrocytes causes age-dependent neurological 
symptoms. Proc Natl Acad Sci U S A. 2009;106(52):22480-5. PMCID: 2799722. 
 
11. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, et 
al. Excess brain protein oxidation and enzyme dysfunction in normal aging and in 
11 
 
Alzheimer disease. Proc Natl Acad Sci U S A. 1991;88(23):10540-3. PMCID: 
52964. 
 
12. Nicolle MM, Gonzalez J, Sugaya K, Baskerville KA, Bryan D, Lund K, et al. 
Signatures of hippocampal oxidative stress in aged spatial learning-impaired 
rodents. Neuroscience. 2001;107(3):415-31. 
 
13. Aksenova MV, Aksenov MY, Carney JM, Butterfield DA. Protein oxidation and 
enzyme activity decline in old brown Norway rats are reduced by dietary 
restriction. Mech Ageing Dev. 1998;100(2):157-68. 
 
14. Cakatay U, Telci A, Kayali R, Tekeli F, Akcay T, Sivas A. Relation of oxidative 
protein damage and nitrotyrosine levels in the aging rat brain. Exp Gerontol. 
2001;36(2):221-9. 
 
15. Perluigi M, Di Domenico F, Giorgi A, Schinina ME, Coccia R, Cini C, et al. Redox 
proteomics in aging rat brain: involvement of mitochondrial reduced glutathione 
status and mitochondrial protein oxidation in the aging process. J Neurosci Res. 
2010;88(16):3498-507. 
 
16. Miquel J, Economos AC, Fleming J, Johnson JE, Jr. Mitochondrial role in cell 
aging. Exp Gerontol. 1980;15(6):575-91. 
 
17. Barja G. Mitochondrial oxygen consumption and reactive oxygen species 
production are independently modulated: implications for aging studies. 
Rejuvenation Res. 2007;10(2):215-24. 
 
18. Arnold B, Cassady SJ, VanLaar VS, Berman SB. Integrating multiple aspects of 
mitochondrial dynamics in neurons: age-related differences and dynamic 
changes in a chronic rotenone model. Neurobiol Dis. 2011;41(1):189-200. 
PMCID: 3021420. 
 
19. Sheng ZH, Cai Q. Mitochondrial transport in neurons: impact on synaptic 
homeostasis and neurodegeneration. Nat Rev Neurosci. 2012;13(2):77-93. 
 
20. Gottlieb RA, Carreira RS. Autophagy in health and disease. 5. Mitophagy as a 
way of life. Am J Physiol Cell Physiol. 2010;299(2):C203-10. PMCID: 2928637. 
 
21. Ross JM, Stewart JB, Hagstrom E, Brene S, Mourier A, Coppotelli G, et al. 
Germline mitochondrial DNA mutations aggravate ageing and can impair brain 
development. Nature. 2013;501(7467):412-5. PMCID: 3820420. 
 
22. Cannon JR, Greenamyre JT. The role of environmental exposures in 
neurodegeneration and neurodegenerative diseases. Toxicol Sci. 
2011;124(2):225-50. PMCID: 3216414. 
 
12 
 
23. Hudnell HK. Effects from environmental Mn exposures: a review of the evidence 
from non-occupational exposure studies. Neurotoxicology. 1999;20(2-3):379-97. 
 
24. Calne DB, Chu NS, Huang CC, Lu CS, Olanow W. Manganism and idiopathic 
parkinsonism: similarities and differences. Neurology. 1994;44(9):1583-6. 
 
25. Wastensson G, Sallsten G, Bast-Pettersen R, Barregard L. Neuromotor function 
in ship welders after cessation of manganese exposure. Int Arch Occup Environ 
Health. 2012;85(6):703-13. 
 
26. Seth PK, Chandra SV. Neurotransmitters and neurotransmitter receptors in 
developing and adult rats during manganese poisoning. Neurotoxicology. 
1984;5(1):67-76. 
 
27. Desole MS, Miele M, Esposito G, Migheli R, Fresu L, Enrico P, et al. 
Monoaminergic systems activity and cellular defense mechanisms in the 
brainstem of young and aged rats subchronically exposed to manganese. 
Neurosci Lett. 1994;177(1-2):71-4. 
 
28. Philbert MA, Nolan CC, Cremer JE, Tucker D, Brown AW. 1,3-Dinitrobenzene-
induced encephalopathy in rats. Neuropathol Appl Neurobiol. 1987;13(5):371-89. 
 
29. Tjalkens RB, Ewing MM, Philbert MA. Differential cellular regulation of the 
mitochondrial permeability transition in an in vitro model of 1,3-dinitrobenzene-
induced encephalopathy. Brain Res. 2000;874(2):165-77. 
 
30. Miller JA, Runkle SA, Tjalkens RB, Philbert MA. 1,3-Dinitrobenzene-induced 
metabolic impairment through selective inactivation of the pyruvate 
dehydrogenase complex. Toxicol Sci. 2011;122(2):502-11. PMCID: 3155080. 
 
31. Steiner SR, Philbert MA. Proteomic identification of carbonylated proteins in 1,3-
dinitrobenzene neurotoxicity. Neurotoxicology. 2011;32(4):362-73. PMCID: 
3158615. 
 
32. Phelka AD, Sadoff MM, Martin BP, Philbert MA. BCL-XL expression levels 
influence differential regional astrocytic susceptibility to 1,3-dinitrobenzene. 
Neurotoxicology. 2006;27(2):192-200. 
 
33. Phelka AD, Beck MJ, Philbert MA. 1,3-Dinitrobenzene inhibits mitochondrial 
complex II in rat and mouse brainstem and cortical astrocytes. Neurotoxicology. 
2003;24(3):403-15. 
 
 
 
13 
 
 
 
CHAPTER II 
 
 
 
Stability of the Mitochondrial Membrane Potential Confers Susceptibility  
to 1,3-DNB Neurotoxicity 
 
 
INTRODUCTION 
 
 
 Notable age-related declines in mammalian mitochondrial function have been 
linked to the normal and accelerate degeneration of brain and other organs.  In aging 
human brains, neuronal and glial mitochondrial metabolism decreases in both neurons 
and glia and are likely responsible for the steady overall loss of function due to the 
dependence of neurons on astrocytes for collateral metabolic and physical support, and 
for maintenance of the composition of the extracellular environment (1). Astrocytes 
participate actively in neuroprotective functions, such as scavenging excess 
extracellular glutamate (2), and regulating extracellular calcium and potassium 
concentrations (3). Astrocytes with functionally intact mitochondria supply energy 
equivalents in the form of adenosine triphosphate (ATP) that is required to maintain 
important neuroprotective functions (4).  Thus, the accumulation of (bio)chemical and 
physical insults to brain mitochondria over time can result in a deterioration in these 
neuroprotective astrocyte functions in older mammals.  Exposure to neurotoxicants that 
selectively target astrocyte mitochondria may, therefore, exacerbate existing or acquired 
metabolic imbalances as a result of aging.   
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1,3-Dinitrobenzene (DNB) is an industrial synthetic intermediate that produces 
focal, bilaterally symmetrical lesions in the brainstem similar to those seen in acute 
energy deprivation syndromes (5).  It has been established that astrocytes within the 
brainstem are a principal cellular target in DNB exposure (4), and that astrocyte 
mitochondria are an organellar target in DNB exposure (6), (7), (8), (9), (10).  Astrocytes 
release adenosine as a neuroprotective mechanism (11).  Extracellular adenosine 
increases significantly in immortalized astrocyte monoculture with corresponding 
increases in DNB concentrations (12), suggesting that DNB exposure causes astrocytes 
to expend their energetic resources toward neuroprotective functions, perhaps at the 
expense of other cellular functions.   
This study seeks to establish evidence of a relationship between age in culture 
(passage number of immortalized astrocytes) and the degree to which astrocytes can 
maintain neuroprotective functions.  Both monoculture astrocytes and cocultures of 
immortalized astrocytes and primary neurons are employed to investigate this 
relationship.       
 
MATERIALS AND METHODS 
 
 
 
Cell Culture 
 Immortalized astrocytes (DI-TNC1) were obtained from the American Type 
Culture Collection and maintained in a humidified incubator at 37°C and 5% CO2.  
Growing media for DI-TNC1 astrocytes consisted of Dulbecco’s Modified Eagle’s 
Medium (DMEM, 25mM D-Glucose, 1mM sodium pyruvate), 10% Fetal Bovine Serum, 
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and 1% Antibiotic/Antimycotic.  Media and additives were vacuum filtered for 
sterilization prior to use. 
Primary neurons were isolated from E18 Sprague-Dawley rat cortex, obtained 
from BrainBits, LLC and maintained in a humidified incubator at 37°C and 5% CO2.  
Isolation of neurons was performed according to the protocol by BrainBits.  Briefly, glass 
coverslips were coated with 50μg/mL Poly-D-Lysine and allowed to adhere at least one 
hour at 37°C.  Coverslips were then subsequently rinsed with sterile water 3 times and 
then allowed to dry under the sterile hood.  Cortices were dissociated with 2mg/mL 
papain in Hibernate E media without calcium (BrainBits, LLC) using a fire-polished glass 
Pasteur pipette.  Papain solution was removed and Hibernate E media (BrainBits, LLC) 
was added to the dissociated tissue.  Tissue was allowed to settle, supernatant was 
spun down to pellet the neurons, and then the pellet was resuspended in Neurobasal 
media supplemented with B-27, Glutamax, and 1% Antibiotic/Antimycotic (all from 
Invitrogen).  Neurons were diluted and then plated at 1.2x105 cells per coverslip.  After 3 
hours, half of the media was removed and fresh supplemented Neurobasal media was 
used to rinse the coverslips 3 times.  Media was then changed every 4-5 days 
afterward.     
 
Mitochondrial Flickering Detection and Analysis 
DI-TNC1 astrocytes were plated onto glass coverslips and grown to ~30-50% 
confluence (18-24 hours) in an incubator (5% CO2, 37°C).  Growing media was 
replaced with DNB dosing media (serum-free DMEM).  One hour after exposure to 
DNB, 10% FBS was supplemented back into the media.  Fifteen minutes prior to 
imaging, the dosing media was aspirated, cells were rinsed gently with Dulbecco’s 
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phosphate buffered saline (DPBS), and 100nM tetramethylrhodamine methyl ester 
(TMRM) (in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid/Hanks’ Balanced Salt 
Solution: HEPES/HBSS buffer) was added.  After a fifteen minute incubation period, the 
TMRM solution was replaced with HEPES/HBSS buffer and the cells were imaged.   
Cells were imaged on an Olympus IX-800 disk scanning unit (DSU) microscope 
at intervals of 500ms for 60 seconds.  Light intensity of the mercury lamp was 
maintained at a constant wattage output, measured by a light meter, so as to maintain 
imaging consistency and to control for phototoxicity.  During imaging, the cells were 
maintained in an environmental chamber (Pathology Devices), set at 5% CO2, 37°C, 
and 60% humidity.  The microscope was controlled using SlideBook software (version 
5.0), and image loops were reviewed immediately following image acquisition.   
 
Bromodeoxyuridine (BrdU) Proliferation Assay in Immortalized Astrocytes 
 
DI-TNC1 astrocytes were plated onto 96-well plates at 5x10
3 cells per well and 
grown to confluence (24 hours) in an incubator (5% CO2, 37°C).  Growing media was 
replaced with DNB dosing media (serum-free DMEM).  One hour after exposure to 
DNB, 10% FBS was supplemented back into the media.  The manufacturer’s 
instructions for the BrdU ELISA (Roche) were followed.  Briefly, BrdU labeling solution 
was added to the wells and allowed to incubate 2-20 hours after exposure to either 
100uM or 600uM DNB (or a v/v equivalent of DMSO as a vehicle control).  At each time 
point (2h, 4h, 8h, 12h, 16h, 20h) the labeling solution was removed from the wells and 
the cells were processed as directed for colorimetric detection of BrdU incorporation. 
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Immunocytochemistry – Primary Neuron Identification   
 
Sprague-Dawley rat E18 cortical tissue (BrainBits, LLC) was dissected as 
directed by the protocol.  Neurons were cultured on poly-D-lysine glass coverslips for 5-
7 days and used for co-culture experiments with astrocytes.  Neurons were fixed with 
4% paraformaldehyde, rinsed with DPBS, and incubated with 4’,6-diamidino-2-
phenylindole (DAPI) alone as a negative control or with DAPI, anti-glial fibrillary acidic 
protein (GFAP) conjugated with Alexafluor-488 to identify astrocytes, and anti-neuronal 
nuclei (NeuN) conjugated with Alexafluor-555 to identify neurons (red).  Neurons were 
imaged on an Olympus IX-800 DSU microscope and images were saved using 
Slidebook software (version 5.3).     
 
 
Ca2+ Visualization using Fluo-4 AM in Primary Neurons 
 
Rat E18 cortical tissue (BrainBits, LLC) was dissected as directed by the 
protocol.  Neurons were cultured for 5-7 days in Neurobasal media (Invitrogen) 
supplemented with Glutamax, B-27 and antibiotic-antimycotic (Invitrogen) on poly-D-
lysine coated glass cover slips and co-cultured with either high passage or low passage 
DI-TNC1 astrocytes using Corning® Trans-well inserts.  After 24h had elapsed, neurons 
and DI-TNC1 astrocytes were exposed to 50uM, 100uM, 200uM, 400uM, or 600uM DNB 
(or v/v equivalent of DMSO (vehicle control; VC)).  At time points at which first flickering 
was observed in DNB exposures in monoculture DI-TNC1 astrocytes, the dosing media 
was removed, the insert containing DI-TNC1 astrocytes was removed, and 1uM Fluo-4 
(Invitrogen), dissolved in Pluronic (Invitrogen) was delivered to neurons in 
HEPES/HBSS buffer.  After a 30 minute incubation in an incubator (5% CO2, 37°C), 
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Fluo-4 was removed, cells were rinsed 2x with HEPES/HBSS buffer, and incubated with 
HEPES/HBSS buffer for 30 minutes in the incubator.  Coverslips were mounted on an 
imaging chamber, 900µl of HEPES/HBSS buffer was added to the chamber, and 
baseline images were captured (60 images, 1s intervals).  At 60s, 100µl of 1M 
potassium chloride (KCl) was added to the chamber (100mM working concentration) to 
induce depolarization of the neuron; images were continuously taken for 5 more 
minutes to monitor the Ca2+ wave during depolarization.  Thapsigargin was used as a 
positive control for intracellular calcium following KCl-induced depolarization. 
 
 
JC-1 Visualization of Mitochondrial Membrane Potential in Primary Neurons 
 Sprague-Dawley rat E18 cortical tissue (BrainBits, LLC) was dissected as 
directed by the protocol.  Neurons were cultured for 5-7 days in Neurobasal media 
(Invitrogen) supplemented with Glutamax, B-27 and antibiotic-antimycotic (Invitrogen) 
on poly-D-lysine coated glass cover slips and co-cultured with either high passage or 
low passage DI-TNC1 astrocytes using Corning® Trans-well inserts.  After 24h had 
elapsed, neurons and DI-TNC1 astrocytes were exposed to 600uM DNB, v/v equivalent 
of DMSO (vehicle control; VC), or 5uM FCCP (positive control for mitochondrial 
depolarization).  At time points at which first flickering was observed in DNB exposures 
in monoculture DI-TNC1 cells at 600uM DNB, the dosing media was removed, the insert 
containing DI-TNC1 cells was removed, and buffer (HEPES/HBSS) containing 5uM JC-1 
was added.  Neurons were incubated with JC-1 at 37°C for 30 minutes.  Following this 
30 minute step, neurons were rinsed 3x with HEPES/HBSS buffer and visualized on an 
Olympus IX-800 DSU microscope (20x).  During imaging, the cells were maintained in 
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an environmental chamber (Pathology Devices), set at 5% CO2, 37°C, and 60% 
humidity.  The following camera settings were used for capturing images:  red 
fluorescence protein (RFP) (Neutral Density 4 (ND4)); green fluorescent protein (GFP) 
(ND4); Range around current: 1um, # planes: 10, step size:  0.1um.  Scale bars were 
added (Annotations tab in Slidebook) and Z-stack was exported as TIF files, 
MultiDimensional View was exported as a TIF file.   
 
Trypan Blue Exclusion – Determination of DI-TNC1 Astrocyte Viability 
 DI-TNC1 astrocytes were co-cultured on Corning® Trans-well inserts for 24h in 
wells containing primary neurons, adhered to coverslips, derived from rat E18 cortical 
tissue (BrainBits, LLC).  The co-culture media (Neurobasal, Glutamax, B-27, antibiotic-
antimycotic) was removed and fresh co-culture media with varying concentrations of 
DNB and VC was added for the following lengths of time:  600uM = 3.5h; 400uM = 9h; 
200uM 12h; 100uM = 20h; 50uM = 22h (these time points and concentrations are 
directly aligned with the time points and concentrations found to induce first flickering 
and morphological changes in LP DI mitochondria).  DI-TNC1 astrocytes were rinsed 
with DPBS, trypsinized, and resuspended in DMEM.  Cell resuspensions were added to 
Trypan Blue (1:1) and cells were counted using a Countess™ automated cell counter 
(Sigma). 
ATP Concentration Assay in Co-cultured Immortalized Astrocytes   
 Sprague-Dawley rat E18 cortical tissue (BrainBits, LLC) was dissected as 
directed by the protocol.  Neurons were cultured for 5-7 days in Neurobasal media 
(Invitrogen) supplemented with Glutamax, B-27 and 1% antibiotic/antimycotic 
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(Invitrogen) on poly-D-lysine coated glass cover slips and co-cultured with either high 
passage or low passage DI-TNC1 astrocytes using Corning® Trans-well inserts.  After 
24h had elapsed, neurons and DI-TNC1 astrocytes were exposed to 50uM, 100uM, 
200uM, 400uM, or 600uM DNB (or v/v equivalent of DMSO (vehicle control; VC)).  At 
time points at which first flickering was observed in DNB exposures in monoculture DI-
TNC1 astrocytes, the dosing media was removed and the ATPLite™ luminescence ATP 
concentration detection assay (PerkinElmer®) was performed as directed by the 
manufacturer.  
Statistical Analysis 
 Fluorescence microscopy data measuring free intracellular calcium in neurons 
(Figures 2.4-2.8) were graphed as a percentage of fluorescence intensity induced by 
addition of KCl; a one-way ANOVA with Tukey’s test for multiple comparisons was used 
to determine significant differences between the exposures, with p<0.05 considered 
statistically significant (Prism software, version 5.0, GraphPad).  Viability of co-cultured 
astrocytes (Figure 2.10) was expressed as the mean live cell count ± SEM, normalized 
to the vehicle control, and values for low passage and high passage astrocytes were 
pooled for comparison by Student’s t-test, with p<0.05 considered statistically 
significant.  ATP levels in astrocytes were shown as relative luminescence units and 
normalized to the vehicle control.  A one-way ANOVA with Tukey’s test for multiple 
comparisons was used to compare the effect of each concentration of DNB on low and 
high passage astrocyte ATP levels; p<0.05 was considered a significant difference 
between the means for each group (Prism software, version 5.0, GraphPad). 
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RESULTS 
Mitochondrial Aspect Ratio and Time to First Mitochondrial Flickering in DI-TNC1 
astrocytes exposed to DNB 
 DNB-induced changes in mitochondrial aspect ratio and concurrent induction of 
first mitochondrial flickering events are shown in Figure 2.1.  A mitochondrial “first 
flickering event” is defined, for the purposes of this study, as the first detectable loss of 
membrane potential, followed immediately by the regain of the membrane potential.  
Mitochondrial flickering was measured using the mitochondrial-specific, potentiometric 
fluorescent dye TMRM, and aspect ratio was measured using MitoTracker® Deep Red.  
Higher passage DI-TNC1 astrocytes exhibited earlier first flickering events (solid blue 
line) and decreased aspect ratio (dashed blue line) in comparison to lower passage DI-
TNC1 astrocytes (time to first flickering event = solid red line, aspect ratio = dashed red 
line).   A regression model (β0+ β1log(DNB Concentration)+ β2log(Exposure time)) was 
run separately for both mitochondrial first flickering and aspect ratio values, and showed 
that trends were statistically significant between passage groups (p<0.05).  A range of 
concentrations of DNB were used for the experiment (600uM, 400uM, 200uM, 100uM, 
and 50uM).  For both passage groups, the higher the concentration of DNB, the earlier 
the average first flickering event occurred.  Decreases in aspect ratio were concurrent 
with detection of first mitochondrial flickering events.    
Proliferation Rates in High Passage and Low Passage DI-TNC1 astrocytes 
 DI-TNC1 astrocyte proliferation rates were measured using an enzyme-linked 
immunosorbent assay (ELISA) for BrdU incorporation into cellular deoxyribonucleic acid 
(DNA) to determine whether or not DNB causes a passage-dependent decrease in cell 
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proliferation.  While there were no statistically significant differences in proliferation 
rates between high passage DI-TNC1 astrocytes and low passage DI-TNC1 astrocytes 
or between vehicle control and DNB-exposed cells within each passage group, some 
proliferation trends do emerge (Figure 2.2):  high passage DI-TNC1 astrocytes’ growth 
curve peaks and then plateaus, whereas low passage astrocytes keep proliferating past 
20 hours, in both control and DNB-exposed groups. 
Immunocytochemistry on Primary Neurons for Cell Identification 
Immunocytochemistry experiments to identify the purity of primary neuron 
cultures used for co-culture experiments identified the cultures to be at least 81% 
neurons on average (Figure 2.3.).   
Free Intracellular Calcium Concentrations in Neurons Co-cultured with Low Passage or 
High Passage Immortalized Astrocytes Exposed to 600uM, 400uM, 200uM, 100uM, 
50uM DNB 
 Free intracellular calcium was detected using the fluorescent dye Fluo-4AM and 
induction of neuronal depolarization by KCl addition.  This was done to determine 
whether or not lower passage astrocytes were better able to defer or prevent 
depolarization in neurons during DNB exposure than higher passage astrocytes.    
Thapsigargin (1uM) was used as a positive control for intracellular calcium, as it blocks 
the sarco/endoplasmic Ca2+ ATPase and raises intracellular calcium stores (13). 
Because adenosine is a neuroprotective metabolite (14), 5uM adenosine was used as 
an additional control by itself, and was also used as a co-treatment with DNB.  
Exposures to DNB were parallel with time-points and concentrations that induced the 
first flickering event (as shown in Figure 2.1).  
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 At 600uM DNB, neurons co-cultured with low passage DI-TNC1 astrocytes 
showed statistically significantly lower levels of intracellular calcium than thapsigargin 
(p<0.05) (Figure 2.4), as did neurons co-cultured with high passage DI-TNC1 astrocytes 
(p<0.001).  Additionally, adenosine alone caused a decrease in neuronal intracellular 
calcium that was statistically significantly lower in both low passage (p<0.05) and high 
passage (p<0.001) co-cultured neurons compared to thapsigargin (Figure 2.4).  
However, in neurons co-cultured with high passage DI-TNC1 astrocytes, there was a 
statistically significant difference between thapsigargin and adenosine/600uM DNB co-
treatment (p<0.001).  There were no statistically significant differences between vehicle 
control and 600uM DNB neuronal intracellular calcium measurements.   
 In co-cultures exposed to 400uM DNB, there were no statistically significant 
differences between 400uM DNB, the vehicle control, adenosine, adenosine/400uM 
DNB co-treatment, or thapsigargin in neurons co-cultured with low passage DI-TNC1 
astrocytes (Figure 2.5).  Intracellular calcium in both adenosine and adenosine/400uM 
DNB co-treatment were statistically significantly lower than thapsigargin (p<0.01) in 
neurons co-cultured with high passage DI-TNC1 astrocytes.  Again, there were no 
statistically significant differences between vehicle control and 400uM DNB neuronal 
intracellular calcium measurements.   
 Both high passage (p<0.001) and low passage (p<0.05) co-cultures exposed to 
200uM DNB exhibited significantly lower intracellular calcium in neurons between 
200uM DNB and thapsigargin, adenosine and thapsigargin, and adenosine/200uM DNB 
co-treatment and thapsigargin (Figure 2.6).  Additionally, in neurons co-cultured with 
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high passage DI-TNC1 astrocytes, the vehicle control was significantly lower than 
thapsigargin (Figure 2.6).   
 Neurons co-cultured with low passage DI-TNC1 astrocytes exposed to 100uM 
DNB exhibited a significantly lower intracellular calcium concentration compared to 
thapsigargin (p<0.05), as did adenosine compared to thapsigargin (p<0.05) and the 
vehicle control compared to adenosine/100uM DNB co-treatment (p<0.05) (Figure 2.7).  
There were several significant differences in intracellular calcium concentration between 
exposures in neurons co-cultured with high passage DI-TNC1 astrocytes:  adenosine 
(p<0.001), vehicle control (p<0.05), and adenosine/100uM DNB co-treatment (p<0.001) 
were all lower than thapsigargin (Figure 2.7).  Additionally, neurons co-cultured with 
high passage DI-TNC1 astrocytes exposed to 100uM DNB showed a significantly higher 
intracellular calcium concentration than adenosine alone (p<0.05) or adenosine/100uM 
DNB co-treatment (p<0.01) (Figure 2.7). 
  The following exposures elicited significantly lower neuronal co-culture 
intracellular calcium concentrations compared to thapsigargin in low passage DI-TNC1 
astrocyte co-cultures:  50uM DNB (p<0.001), adenosine (0.01), and adenosine/50uM 
DNB co-treatment (p<0.01) were significantly lower than thapsigargin; whereas 
neuronal intracellular calcium in the vehicle control was significantly higher than 
adenosine (p<0.05), adenosine/DNB co-treatment (p<0.05), and 50uM DNB (p<0.001) 
(Figure 2.8, red asterisks).  Neuronal intracellular calcium was significantly higher in 
thapsigargin treatment compared to 50uM DNB exposure (p<0.05), the vehicle control 
(p<0.01), adenosine (p<0.001), and adenosine/50uM DNB co-treatment (p<0.001) in 
high passage DI-TNC1 astrocyte co-cultures (Figure 2.8).   
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Mitochondrial Membrane Potential in Co-Cultured Neurons Exposed to 600uM DNB 
 
Mitochondrial membrane potential in co-cultured neurons was measured using 
the cationic carbocyanine dye JC-1.  This experiment was performed to determine 
whether or not DNB exposure caused depolarization of neuronal mitochondria 
dependent on the passage number of the DI-TNC1 astrocytes with which they were 
cultured.  Neurons co-cultured with high passage DI-TNC1 astrocytes exposed to 
600uM DNB exhibit more depolarized mitochondria compared to their counterparts co-
cultured with low passage DI-TNC1 astrocytes (Figure 2.9). 
Viability of High Passage and Low Passage Co-Cultured DI-TNC1 Astrocytes Exposed 
to DNB 
To determine whether or not low passage DI-TNC1 astrocytes are better able to 
survive DNB exposure than high passage DI-TNC1 astrocytes while co-cultured with 
neurons, a trypan blue exclusion assay was performed to determine the cell viability of 
co-cultured DI-TNC1 astrocytes .  The total number of live cells was higher for both 
control and DNB-exposed high passage co-cultured DI-TNC1 astrocytes compared to 
low passage (Figure 2.10).  When normalized to the control, however, low passage DI-
TNC1 astrocytes exhibited relatively higher viability, of which no comparison was 
statistically significant.  When the normalized live cell counts were pooled for each 
passage group, viability of high passage DI-TNC1 astrocytes were statistically 
significantly lower than low passage DI-TNC1 astrocytes. 
ATP Measurements in Co-Cultured DI-TNC1 Astrocytes Exposed to DNB 
Because high passage DI-TNC1 astrocytes are functionally different from low 
passage DI-TNC1 astrocytes in that they are less able to protect neurons (Figures 2.4-
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2.8), exhibit an unstable mitochondrial membrane potential (Figure 2.1), and exhibit 
decreased viability in co-culture in DNB exposure (Figure 2.10), an ATP assay was 
performed to determine whether or not high passage DI-TNC1 astrocytes have lower 
ATP concentrations than low passage.  A luminescence assay from PerkinElmer®, 
ATPLite™, was used to determine relative ATP levels between high and low passage 
cells.  The ATPLite™ assay utilizes luciferin to catalyze an enzymatic reaction 
converting ATP, D-Luciferin, and O2 to oxyluciferin, adenosine monophosphate, 
inorganic diphosphate, CO2, and light.  This light is measured by a luminometer; the 
amount of measured light correlates to the amount of ATP in the cells.  At all 
concentrations of DNB (600uM, 400uM, 200uM, 100uM, and 50uM), measured ATP 
levels were lower for low passage co-cultured DI-TNC1 astrocytes than high passage 
(Figure 2.11).  However, there were no statistically significant differences between any 
of the DNB concentrations and controls.   
 
 
DISCUSSION 
The data demonstrate that in monoculture, mitochondria in high passage DI-
TNC1 astrocytes are more susceptible to DNB-induced alterations in mitochondrial 
morphology and mitochondrial membrane potential than low passage DI-TNC1 
astrocytes.  Passage #-dependent susceptibility was determined to be dependent on 
both the concentration of DNB and length of exposure:  the higher the concentration of 
DNB exposure, the earlier a mitochondrial first flickering event would occur concurrently 
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with a decrease in aspect ratio.  At each concentration of DNB, the higher the passage 
number, the earlier mitochondria had exhibited a first flickering event and concurrent 
morphological change.   
Existing literature shows evidence supporting the relationship between a 
decrease in mitochondrial membrane potential and change in mitochondrial shape, and 
a related decrease in mitochondrial function (15).  This evidence, combined with novel 
data put forth in this chapter showing that high passage DI-TNC1 astrocytes co-cultured 
with neurons are less likely to survive DNB exposure than low passage DI-TNC1 
astrocytes suggests that perturbations to mitochondria in monoculture DI-TNC1 
astrocytes correspond with a decrease in co-cultured DI-TNC1 astrocyte viability.  It is 
possible that the onset of the first flickering event is an early indicator of DNB-induced 
metabolic stress in monoculture DI-TNC1 astrocytes, which is likely exacerbated when 
DI-TNC1 astrocytes are in a co-culture system.  A novel aspect of this research is that 
the relationship between mitochondrial membrane potential, mitochondrial aspect ratio 
and astrocyte viability is mediated by the passage number of the astrocytes themselves, 
suggesting that passage number may be an in vitro proxy for in vivo cellular age.    
 High passage DI-TNC1 astrocytes showed attenuated proliferation compared to 
low passage DI-TNC1 astrocytes.  Additionally, low passage DI-TNC1 astrocytes did not 
exhibit deviations from proliferation rates when exposed to 600uM DNB.  In high 
passage DI-TNC1 astrocytes exposed to 600uM DNB, however, proliferation rates 
decreased.  Because cellular proliferation is an “energy-expensive” process and 
requires functional mitochondria, this could indicate one or more of the following 
regarding mitochondria in high passage DI-TNC1 astrocytes compared to their lower 
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passage counterparts:  1) that there are fewer mitochondria overall, 2) that they contain 
the same number of mitochondria (or more), but there are fewer functional mitochondria 
in high passage DI-TNC1 astrocytes, or 3) that there are fewer mitochondria overall, and 
that they are less functional than in low passage DI-TNC1 astrocytes.  It is most likely 
the second is true, as it has been shown that mitochondrial DNA (mtDNA) copy number 
increases with age in rodent brain (16) (indicating more mitochondria overall), 
mitochondrial enzyme activity decreases in the aging brain (17), and mtDNA mutations 
(18) and oxidative mtDNA damage increase (19).  However, measures of mtDNA (copy 
number, mutations, and oxidative damage) and enzyme activity in different regions of 
the brain are not necessarily reflective of what is occurring between and within cell 
types in those regions, and is likely differential between neurons and astrocytes.  
  Both high and low passage DI-TNC1 astrocytes prevented depolarization (as 
measured by monitoring intracellular Ca2+ after KCl addition) in co-cultured neurons 
when exposed to 600uM or 400uM DNB.  However, in co-culture, high passage DI-
TNC1 astrocytes exposed to high concentrations of DNB (600uM and 400uM) prevented 
depolarization of neurons when co-treated with adenosine and DNB together; this was 
not observed with low passage DI-TNC1 astrocytes.  It’s possible that low passage DI-
TNC1 astrocytes had the ability to precondition the extracellular space with adenosine 
endogenously, which resulted in no significant differences in depolarization in low 
passage co-cultured DI-TNC1 astrocytes when exposed to both adenosine and the 
highest concentrations of DNB used (600uM and 400uM).   
 Overall, neurons co-cultured with low passage co-cultured DI-TNC1 astrocytes 
exhibited a more pronounced decrease in intracellular neuronal Ca2+ when exposed to 
29 
 
DNB, suggesting that low passage DI-TNC1 astrocytes are better equipped to perform 
neuroprotective functions than high passage DI-TNC1 astrocytes.  This supposition is 
bolstered by data shown in this chapter in which DNB exposure causes increased 
mitochondrial depolarization in neurons co-cultured with high passage DI-TNC1 
astrocytes compared to neurons co-cultured with low passage DI-TNC1 astrocytes.      
 ATP has been shown to be a major signaling molecule released from astrocytes 
into the extracellular environment, stimulated by glutamate (3), high potassium 
concentrations (20), and other stimuli.  In this study, ATP concentrations were higher in 
high passage DI-TNC1 co-cultured astrocytes than in low passage astrocytes, which 
wasn’t expected.  This could, however, be explained partially by the fact that the 
astrocytes required trypsinization and subsequent resuspension in media to release 
them from the co-culture device to be analyzed for ATP concentrations in a separate 
96-well plate.  Because the astrocytes were removed from the original co-culture media 
(in which there was the opportunity for crosstalk with neurons and the necessary 
neurotransmitters and extracellular metabolites), the replacement of the experimental 
media with fresh media would not have allowed for measurement of extracellular ATP 
that may have been secreted by the astrocytes in response to DNB exposure.  
Therefore, the data from this chapter may be reflective of only intracellular ATP stores.   
 This data suggests that low passage co-cultured DI-TNC1 astrocytes may be 
continually shuttling ATP into the extracellular space in response to futile redox cycling 
of DNB, where it can be catabolized further into adenosine (21).  Additionally, it has 
previously been shown that the addition of extracellular ATP to astrocyte/neuron co-
cultures results in resistance to oxidative injury as robust in primary astrocytes from old 
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mice as in young mice (22).  Because low passage DI-TNC1 astrocytes were better able 
to survive DNB exposure when co-cultured with neurons, the data also suggests that 
low passage DI-TNC1 astrocytes contain mitochondria that are able to expend ATP to 
the extracellular environment while maintaining higher overall viability in contrast with 
co-cultured high passage DI-TNC1 astrocytes.  
 In summary, this study provides novel evidence of increased passage number as 
a surrogate for age in immortalized DI-TNC1 astrocyte mono- and co-culture.  
Mitochondria in high passage DI-TNC1 astrocytes demonstrated an increased 
susceptibility to DNB exposure compared to low passage, which ultimately correlated 
with a decrease in their function in co-culture with neurons.  Future studies will need to 
elucidate possible polymorphic phenotypic differences between high and low passage 
DI-TNC1 astrocytes that may define the functional differences observed in this study. 
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Figure 2.1. Mitochondrial Aspect Ratio and Time to First Mitochondrial Flickering Decrease as a 
Function of Passage Number in Immortalized Astrocytes Exposed to DNB Low Passage # (Passage 
4 through Passage 8; “P4~P8”) and High Passage # (Passage 9 through Passage 30; “P9~P30”) 
immortalized astrocytes exposed to varying concentrations of DNB.  Solid blue and red lines show trends 
for time in hours to first mitochondrial flickering event; all β values were statistically significant (p<0.05) for 
first mitochondrial flickering trends. Dashed blue and red lines show trends for mean aspect ratio (AR). 
Dashed blue and red lines show mean aspect ratio (AR) =5 predicted from following regression model: 
mean aspect ratio = β0+ β1log(DNB Concentration) + β2log(Exposure time); All β values were statistically 
significant (p<0.05) for AR trends. 
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Figure 2.2.  Proliferation Rates in High Passage and Low Passage Immortalized Astrocytes 
Bromodeoxyuridine incorporation ELISA measured in LP (P4-P8) and HP (P19-P26) monoculture 
immortalized astrocytes exposed to either 100uM or 600uM or v/v equivalent of DMSO as a vehicle 
control (VC).  Untreated cell proliferation was also assessed.   
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Figure 2.3. Immunocytochemistry on Primary Neurons for Cell Identification  
Rat E18 cortical neurons were cultured on glass coverslips for 5-7 days and used for co-culture 
experiments with astrocytes.  Neurons were fixed with 4% paraformaldehyde and incubated with DAPI 
alone as a negative control (left panel) or with DAPI, anti-glial fibrillary acidic protein (GFAP) conjugated 
with Alexafluor-488 to identify astrocytes (green), and anti-neuronal nuclei (NeuN) conjugated with 
Alexafluor-555 to identify neurons (red).    Average % neurons across all cultures for co-culture 
experiments = 81% (n=10). 
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Figure 2.4.  Free Intracellular Calcium Concentrations in Neurons Co-cultured with Low Passage or High Passage Immortalized 
Astrocytes Exposed to 600uM DNB  
Low passage immortalized astrocytes (Left panel) and High Passage (Right Panel) were co-cultured with primary cortical neurons and exposed to 
600uM DNB or the equivalent v/v amount of DMSO.  Fluo-4 AM fluorescent dye was added to neurons to measure free intracellular Ca
2+
 
concentrations.  Sixty images were taken at 1s intervals prior to the addition of KCl; 300 images were taken at 1s intervals following KCl addition.  
The average fluorescence intensity of the field of view for each time point was calculated as a percent of the minimum average fluorescence 
induced by KCl addition.  For comparisons across the entire time course of the experiment, a 1-way ANOVA with Tukey’s Multiple Comparison 
Test was performed; asterisks denoting a statistically significant difference between an exposure and thapsigargin are indicated in the legend next 
to the exposure that was significantly different from thapsigargin.  
35 
 
 
Figure 2.5.  Free Intracellular Calcium Concentrations in Neurons Co-cultured with Low Passage or High Passage Immortalized 
Astrocytes Exposed to 400uM DNB  
Low passage immortalized astrocytes (Left panel) and High Passage (Right Panel) were co-cultured with primary cortical neurons and exposed to 
400uM DNB or the equivalent v/v amount of DMSO.  Fluo-4 AM fluorescent dye was added to neurons to measure free intracellular Ca
2+
 
concentrations.  Sixty images were taken at 1s intervals prior to the addition of KCl; 300 images were taken at 1s intervals following KCl addition.  
The average fluorescence intensity of the field of view for each time point was calculated as a percent of the minimum average fluorescence 
induced by KCl addition. For comparisons across the entire time course of the experiment, a 1-way ANOVA with Tukey’s Multiple Comparison 
Test was performed; asterisks denoting a statistically significant difference between an exposure and thapsigargin are indicated in the legend next 
to the exposure that was significantly different from thapsigargin.  
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Figure 2.6. Free Intracellular Calcium Concentrations in Neurons Co-cultured with Low Passage or High Passage Immortalized 
Astrocytes Exposed to 200uM DNB  
Low passage immortalized astrocytes (Left panel) and High Passage (Right Panel) were co-cultured with primary cortical neurons and exposed to 
200uM DNB or the equivalent v/v amount of DMSO.  Fluo-4 AM fluorescent dye was added to neurons to measure free intracellular Ca
2+
 
concentrations.  Sixty images were taken at 1s intervals prior to the addition of KCl; 300 images were taken at 1s intervals following KCl addition.  
The average fluorescence intensity of the field of view for each time point was calculated as a percent of the minimum average fluorescence 
induced by KCl addition. For comparisons across the entire time course of the experiment, a 1-way ANOVA with Tukey’s Multiple Comparison 
Test was performed; asterisks denoting a statistically significant difference between an exposure and thapsigargin are indicated in the legend next 
to the exposure that was significantly different from thapsigargin.   
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Figure 2.7. Free Intracellular Calcium Concentrations in Neurons Co-cultured with Low Passage or High Passage Immortalized 
Astrocytes Exposed to 100uM DNB  
Low passage immortalized astrocytes (Left panel) and High Passage (Right Panel) were co-cultured with primary cortical neurons and exposed to 
100uM DNB or the equivalent v/v amount of DMSO.  Fluo-4 AM fluorescent dye was added to neurons to measure free intracellular Ca
2+
 
concentrations.  Images were taken at 1s intervals prior to the addition of KCl; 300 images were taken at 1s intervals following KCl addition.  The 
average fluorescence intensity of the field of view for each time point was calculated as a percent of the minimum average fluorescence induced 
by KCl addition. For comparisons across the entire time course of the experiment, a 1-way ANOVA with Tukey’s Multiple Comparison Test was 
performed; asterisks denoting a statistically significant difference between an exposure and thapsigargin are indicated in the legend next to the 
exposure that was significantly different from thapsigargin.  Statistically significant differences between 100uM DNB and other exposures are 
denoted by a bar between 100uM DNB and that exposure (level of significance denoted in legend).   
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Figure 2.8.  Free Intracellular Calcium Concentrations in Neurons Co-cultured with Low Passage or High Passage Immortalized 
Astrocytes Exposed to 50uM DNB  
Low passage immortalized astrocytes (Left panel) and High Passage (Right Panel) were co-cultured with primary cortical neurons and exposed to 
50uM DNB or the equivalent v/v amount of DMSO.  Fluo-4 AM fluorescent dye was added to neurons to measure free intracellular Ca
2+
 
concentrations.  Sixty images were taken at 1s intervals prior to the addition of KCl; 300 images were taken at 1s intervals following KCl addition.  
The average fluorescence intensity of the field of view for each time point was calculated as a percent of the minimum average fluorescence 
induced by KCl addition. For comparisons across the entire time course of the experiment, a 1-way ANOVA with Tukey’s Multiple Comparison 
Test was performed; asterisks denoting a statistically significant difference between an exposure and thapsigargin are indicated in the legend next 
to the exposure that was significantly different from thapsigargin (black asterisks); red asterisks denote a significant difference between the vehicle 
control and the denoted exposure.
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Figure 2.9. Mitochondrial Membrane Potential in Co-cultured Neurons Exposed to 600uM DNB 
Low passage (LP = P4-6; left panels) and high passage (HP = P24-28; right panels) immortalized 
astrocytes were co-cultured with primary cortical neurons and exposed to 600uM DNB (top panel), the v/v 
equivalent of DMSO as a vehicle control (VC – middle panel), or 5uM FCCP (bottom panel).  Neurons 
were incubated with JC-1, a cationic carbanocyanine dye that accumulates in mitochondria.  JC-1 forms 
aggregates in mitochondria with intact membrane potential (red) and in depolarized mitochondria remains 
in the monomeric form (green).   
LP = Low Passage; HP = High Passage; VC = v/v DMSO vehicle control      
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Figure 2.10. Viability of Co-cultured Immortalized Astrocytes by DNB Concentration and Passage 
Number  
Low passage (P4-6) and high passage (P24-28) immortalized astrocytes were co-cultured with primary 
cortical neurons and exposed to DNB (50-600uM) or the equivalent v/v amount of DMSO.  Immortalized 
astrocytes were trypsinized and then subsequently counted using the Countess® cell counter by trypan 
blue exclusion assay.  Raw live cell counts are shown (Top Left).  Live cell counts for DNB exposed 
immortalized astrocytes were then normalized to the vehicle control live cell count.  Individual values of 
normalized live cell counts for stratified by DNB concentration (Top Right) and pooled live cell counts 
stratified by passage number (Bottom Center; data were uploaded to Prism software (Version 5.0, 
GraphPad) for statistical analysis (student’s t-test).   
LP = Low Passage; HP = High Passage; VC = v/v DMSO vehicle control     
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Figure 2.11. ATP Measurements in Co-cultured Immortalized Astrocytes Exposed to DNB  
Low passage (P4-5) and high passage (P24-25) immortalized astrocytes were co-cultured with primary 
cortical neurons and exposed to DNB (50-600uM) or the equivalent v/v amount of DMSO.  Astrocytes 
were then removed from the co-culture system, and ATP levels were measured using the PerkinElmer® 
ATPLite™ kit; manufacturer’s protocol was followed.  Data were uploaded to Prism software (Version 5.0, 
GraphPad) for statistical analysis (one-way ANOVA with Tukey’s Test for Multiple Comparisons).   
VC = v/v DMSO vehicle control     
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CHAPTER III 
 
 
 
Determine Whether or not the Degree of DNB-Induced Oxidation of Mitochondria-
Related Proteins in Susceptible Brainstem Regions is Dependent on Age 
 
 
 
INTRODUCTION 
 
The free radical theory of aging, first put forth nearly sixty years ago, postulated 
that the aging process was related to the accumulation of oxidative damage to 
macromolecules (1).  During the physiological aging process, the brain accumulates 
oxidative damage [reviewed by Halliwell (2)].  However, the amount of accumulated 
oxidative modifications to macromolecules varies by region, including age-associated 
increases in lipid peroxidation in cerebral hemisphere, cerebellum, and to a lesser 
extent, in brainstem compared to younger rats (3), increased formation of DNA adducts 
in substantia nigra of aged rats compared to younger rats (4), and increased protein 
oxidation in brainstem (5).  The mitochondrion is particularly susceptible to oxidative 
damage, as the mitochondrion itself produces reactive oxygen species (6), (7), (8), and 
antioxidant concentrations decrease in brain mitochondria over time (9), (10).  
Additionally, there is age-dependent, regional variation in antioxidant levels in rodent 
brain (11) and human brain (12), (13).  This evidence suggests that mitochondrial 
macromolecules within specific regions of the brain may be especially prone to 
oxidation over time. 
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The mitochondrial proteome in the brain accrues oxidative modifications during 
aging (9).  Accumulation of posttranslational modifications can lead to alterations in 
protein function in mitochondria, some of which may be dysfunctional.  Exposure to 1,3-
Dinitrobenzene (DNB) in rodents results in bilaterally symmetrical spongiform lesions 
(14).  Due in part to its ability to undergo futile redox cycling during metabolism (15), 
DNB has been shown to cause oxidative stress typically localized to the brainstem, 
where lesions are evident, including increased carbonylation in brainstem mitochondria 
(Dr. Stephen Steiner, unpublished data) and increased carbonylation in astrocyte 
mitochondria (16).  Because oxidation that accrues during aging in the brain is highly 
region-specific and DNB selectively targets the brainstem, this study’s hypothesis is that 
age will exacerbate mitochondrial susceptibility to DNB-induced protein oxidation in the 
brainstem. 
Exposure to environmental neurotoxicants has been shown to cause age-
dependent, regional variation in elevated oxidative stress (as noted in rodent exposure 
to toluene (17).  However, there is very little evidence of age-related increases in 
mitochondria-specific, region-specific oxidative accumulation in response to 
neurotoxicant exposure.  This study uses a high-throughput proteomic approach to 
provide novel evidence of DNB-induced mitochondrial proteome oxidation localized to 
brainstem mitochondria; advanced age of the animal exacerbates the extent and 
specific peptide loci of the mitochondrial proteome oxidation. 
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MATERIALS AND METHODS 
 
 
Animals 
 Male F344 rats (1 month old, 3 month old, and 18 month old) were purchased 
from Harlan Laboratories and housed according to University of Michigan’s University 
Committee on Use and Care of Animals policies.  Rats were fed and watered ad libitum 
and housed on a 12-hour light/dark cycle.   
Histology 
Rats from each age group were either exposed to 10mg/kg DNB or a v/v 
equivalent of dimethylsulfoxide (DMSO) serving as a vehicle control (at 0h, 4h, and 24h; 
sacrifice occurred 12h after the 24h dose).  Rats were anesthetized with isoflurane, 
followed by opening of the abdominal and thoracic cavity via lateral incisions.  The 
diaphragm was cut away from the heart and lungs.  Normal saline was perfused by 
insertion of a butterfly needle to the left ventricle, followed by an incision to the right 
atrium.  Once the blood was cleared (approximately 7-11 minutes), the rat was 
perfusion fixed with 4% paraformaldehyde (PFA) (approximately 8 minutes).  Directly 
after perfusion fixation, the rat was decapitated via guillotine.  The brain was then 
carefully removed from the skull and placed in 4% PFA overnight prior to paraffin 
embedding.  Embedding, hematoxylin/eosin staining, and sectioning were performed at 
the ULAM Pathology Core for Animal Research (University of Michigan, Ann Arbor). 
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Mitochondrial Isolation 
 Rats from each age group were either exposed to 10mg/kg DNB or a v/v 
equivalent of dimethylsulfoxide (DMSO) serving as a vehicle control (at 0h, 4h, and 24h; 
sacrifice occurred 24h after the 24h dose).  Mitochondria were isolated according to the 
protocol (Method C) by Sims & Anderson (18), with minor modifications.  Briefly, the rat 
was anesthetized under isoflurane, decapitated with a small animal guillotine, and the 
brain was rapidly removed.  Brainstem and cortex were dissected from the rest of the 
brain in cold isolation buffer (100mM Tris, 10mM potassium-EDTA, 960mM sucrose, pH 
7.4).  Brainstem and cortex were then weighed and minced in cold isolation buffer.  
Minced tissue was then homogenized using a glass Dounce homogenizer on ice; this 
step was performed while being flushed with argon.  Subsequent centrifugation steps 
followed.  Prior to the Percoll gradient centrifugation step, digitonin was added to disrupt 
synaptosomal membranes.  Mitochondria were stored at -80°C. 
Detection and Identification of Mitochondria-Related Proteins and Oxidative Modification 
Sites (University of Michigan Peptide Synthesis and Proteomics Core and MSBioWorks, 
LLC, Ann Arbor, MI) 
The volume of each submitted mitochondrial sample was reduced 50% and 20µL of 
the concentrated sample was processed by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) on a 4-12% Bis-Tris Mini-gel (Invitrogen) using the MOPS 
buffer system and non-reducing Laemmli buffer.  Each gel lane was excised into ten 
equal bands and these were processed by in-gel digestion using a robot (ProGest, 
DigiLab): bands were washed with 25mM ammonium bicarbonate followed by 
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acetonitrile, reduced with 10mM dithiothreitol at 60°C followed by alkylation with 50mM 
iodoacetamide at room temperature, digested with trypsin (Promega) for 4h at 37°C, 
and quenched with formic acid and the supernatant was analyzed directly without 
further processing.  Samples were then analyzed by LC/MS/MS analyzed by nano 
LC/MS/MS with a Waters NanoAcquity high performance liquid chromatography (HPLC) 
system interfaced to a ThermoFisher Q Exactive mass spectrometer. Peptides were 
loaded on a trapping column and eluted over a 75µm analytical column at 350nL/min; 
both columns were packed with Jupiter Proteo resin (Phenomenex).  The mass 
spectrometer was operated in data-dependent mode, with MS and MS/MS performed at 
70,000 and 17,500 FWHM resolution, respectively. The fifteen most abundant ions were 
selected for MS/MS. Proteins were identified by reference to the UniProt rat database 
(forward and reverse appended with common contaminant proteins) using the Mascot 
search engine. Results were displayed in Scaffold software. 
Pathway Analysis 
 UniProtID numbers for proteins <0.25-fold or >4.0-fold oxidized, as determined 
by %Oxidation (unweighted spectral count of oxidized protein/total unweighted spectral 
count), were uploaded to the Database for Annotation, Visualization, and Integrated 
Discovery (2).  Pathways were identified by selecting Gene Ontology Term (GOTerm) 
Molecular Function.  Options for pathway determination were set to:  3 proteins to 
constitute a pathway (default setting = 2), and 0.05 as a significance level for P-values 
and Benjamini values.  
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Immunohistochemical Detection of Protein Carbonylation in Brain Sections  
 The methods to detect protein carbonyls in fixed brain tissue were followed as 
described by Smerjac and Bizzozero (19).  1mo, 3mo, and 18mo rats were exposed to 
DNB (10mg/kg) or a v/v equivalent of DMSO as a vehicle control (i.p. injection) at 0h, 
4h, and 24h; 12h after the 24h exposure, rats were anesthetized with isoflurane, 
followed by opening of the abdominal and thoracic cavity via lateral incisions.  The 
diaphragm was cut away from the heart and lungs.  Normal saline was perfused by 
insertion of a butterfly needle to the left ventricle, followed by an incision to the right 
atrium.  Brains were removed and immersion-fixed in methacarn for approximately 2 
hours followed by trimming, cassetting, and overnight immersion fixation in methacarn.   
Sections were then rinsed in methanol two times and 70% ethanol two times before 
tissue processing.   
The methods to detect protein carbonyls in fixed brain tissue will be followed as 
described by Smerjac and Bizzozero (19).  Briefly, carbonylation of proteins were 
detected by conversion of carbonyl groups into 2,4-dinitrophenyl hydrazones by 
incubation with 2,4-dinitrophenyl-hydrazine, followed by a rinse step and incubation with 
a primary antibody for 2,4-dinitrophenol and subsequently a horseradish peroxidase-
labeled secondary antibody.  Controls for this method include section incubation with 
iron hydroxide as a positive control or sodium borohydride as a negative control.   
Statistical Analysis 
 Both global oxidation of MRPs (Figure 3.4) and regional oxidation (Figure 3.5) 
were shown as an average fold-change and compared using a Student’s t-test, with 
p<0.05 considered statistically significant (Prism software, version 5.0, GraphPad). 
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 RESULTS 
Conditions and Mortality Rates of Male F344 Rats Sacrificed 24h after Last Exposure 
 
All animals were monitored for clinical signs of intoxication throughout the 
exposure time course.  In animals exposed at 0h, 4h, 24h with a 24h period after the 
last dose to sacrifice, the oldest rats (18mo) exhibited clinical signs of intoxication in 
DNB exposure including ataxia (100%) and chromodacryorrhea (100%); this group also 
exhibited a 60% mortality rate.  No clinical signs were observed in the 1mo group, and 
only 25% of the 3mo DNB exposed animals were ataxic (Table 3.1). 
Conditions and Mortality Rates of Male F344 Rats Sacrificed 12h after Last Exposure 
 
In animals exposed at 0h, 4h, 24h with a 12h period after the last dose to 
sacrifice, the oldest rats (18mo) exhibited clinical signs of intoxication in DNB exposure 
including ataxia (100%) and chromodacryorrhea (100%); however, all of the animals 
survived the exposure duration.  No clinical signs were observed in the 1mo or the 3mo 
animals (Table 3.2). 
Deep Cerebellar Nuclei in 1mo, 3mo, 18mo Male F344 Rats Exposed to DNB 
No lesions were found in deep cerebellar nuclei in 1mo (Figure 3.1.) or 3mo 
(Figure 3.2.) rats exposed to DNB.  However, there was vacuolation of the neuropil in 
18mo DNB exposed rats (Figure 3.3). 
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Effects of DNB on Global Oxidation of Mitochondria-Related Proteins (MRPs) 
 
DNB had little to no effect on global oxidation of MRPs (Figure 3.4), suggesting 
that the degree of oxidation within individual regions of the brain may be more 
significant than the amount of MRP oxidation in the whole brain. 
Effects of DNB on Regional MRP Oxidation 
 
In young rats (1mo), DNB caused a reduction in oxidation (0.25-fold change) in only 
one MRP in brainstem (acetyl-CoA acetyltransferase, mitochondrial) and did not cause 
any changes in oxidation in any cortical MRPs (Table 3.3).  DNB did not cause 
significant changes in MRP oxidation in brainstem or cortex of 3mo rats (Table 3.3).  
DNB caused the oxidation of 7 MRPs (>4.0-fold) in brainstem from 18mo animals, but 
none in cortex (Table 3.3). 
Effects of Age on Regional MRP Oxidation 
There were no differences in MRP oxidation observed in 3mo brainstem or cortex 
when compared to 1mo MRP oxidation; however, DNB caused the oxidation of 4 MRPs 
in cortex and 13 MRPs in brainstem (>4.0-fold) in 18mo animals compared to 1mo 
(Table 3.4). 
Brainstem and Cortex MRP Oxidation 
The degree to which DNB oxidizes MRPs is significantly higher in brainstem than 
in cortex (Figure 3.5.).  With respect to MRPs oxidized >4.0-fold or greater, brainstem 
MRPs are approximately 3x more sensitive than cortical counterparts (Figure 3.5). 
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Pathways Significantly Oxidized by DNB in Brainstem 
Five GOTerm Molecular Function pathways were significantly oxidized by DNB in 
brainstem (cation transmembrane transporter activity, nucleoside-triphosphatase 
activity, pyrophosphatase activity, hydrolase activity acting on acid anhydrides in 
phosphorous-containing anhydrides, and hydrolase activity acting on acid anhydrides). 
Four of the five identified pathways contain the same three proteins (cytoplasmic dynein 
1 heavy chain 1, tubulin beta-2a chain, and plasma membrane calcium-transporting 
ATPase 2) (Table 3.5).   
Age-Related Carbonylation in 1mo, 3mo, 18mo F344 Rats 
In all 3 age groups, asymmetrical perinuclear staining in neurons was observed 
in deep cerebellar nuclei and vestibular nuclei (Figures 3.6, 3.7, 3.8) both in vehicle 
control and DNB exposed animals, but appears to become more pronounced in 18mo 
deep cerebellar nuclei (Figure 3.8).  No lesions were found in deep cerebellar nuclei, 
vestibular nuclei, or cortex in 1mo (Figure 3.6.) or 3mo (Figure 3.7.) rats exposed to 
DNB.  However, there was vacuolation of the neuropil in the deep cerebellar nuclei and 
vestibular nuclei in 18mo DNB exposed rats (Figure 3.8), but not in cortex. 
 
DISCUSSION 
 There are likely multiple environmental exposures occurring over time that cause 
oxidative stress and contribute to a net increase in risk of developing adverse 
neurological outcomes during aging.  This study gives evidence of increasing age 
exacerbating mitochondrial toxicity in the brainstem during exposure to an 
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environmental neurotoxicant, DNB.  Exposure to DNB resulted in clinical signs of 
intoxication, which were most severe in the 18mo animals, and were consistent with 
previous findings involving DNB exposure and onset of ataxia (14).  While it was 
previously reported that DNB exposure (10mg/kg i.p. injection) causes ataxia in rats, 
this study provides novel evidence of severity of clinical signs of intoxication being 
positively correlated with age:  severe ataxia and onset of chromodacryorrhea were 
observed in the oldest group of animals exposed to DNB (18mo), whereas there were 
very few cases of ataxia in the 3mo animals (25% of exposed animals at most) and no 
instances of ataxia, or any other clinical signs of intoxication, in 1mo DNB-exposed 
animals.  There is supporting evidence in the literature regarding increasing age and the 
increased likelihood of an environmental exposure causing adverse neurological 
outcomes:  paraquat exposure and dopamine depletion in mice (20), cypermethrin 
exposure and dopaminergic neurodegeneration in rats (21), lead exposure and 
decreased dexterity in humans (22), and lead exposure and decreased brain volume in 
humans (23).   
A key finding in this study is that areas of the brain affected by DNB exposure 
(deep cerebellar nuclei) are more susceptible to lesions in older animals than younger 
animals exposed to DNB.  The development of vacuolated lesions in deep cerebellar 
nuclei in 18mo animals suggests that astrocyte foot processes are more susceptible to 
swelling in older animals (and is consistent with histopathological findings in previous 
studies on DNB exposure (14).  Additionally, the development of DNB-induced lesions 
in 18mo animals (and not in younger DNB-exposed animals) correlates with the 
development of clinical signs of intoxication in DNB-exposed animals.  This suggests 
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that the observed lesions are related to the pathophysiological mechanisms induced by 
DNB exposure (i.e.: an increase in reactive oxygen species (ROS)) that is likely causing 
the observed clinical signs of intoxication.  This presumption is supported by the 
following evidence:  astrocyte swelling is observed as a result of increased ROS and 
imbalances in osmotic pressure (24), and astrocyte swelling is observed in cases of 
ataxia caused by exposure to mycotoxin in rat (25) and megalencephalic 
leucoencephalopathy in humans (26).   
This study provides a link between aging, regional specificity of lesions, clinical 
signs of DNB-induced intoxication, and specific patterns of mitochondria-related protein 
oxidation.  Novel data put forth in this chapter gives evidence of two distinct, but 
potentially related concepts:  that brainstem MRPs are more susceptible to oxidation 
than cortical MRPs, and that MRPs from mitochondria in older animals are more 
susceptible to oxidation by DNB than their younger counterparts.  While DNB didn’t 
cause an increase in global MRP oxidation, this suggests that specific regions of the 
brain (namely the brainstem) may be more susceptible to MRP oxidation than the whole 
brain, which may have been masked by an assessment of global MRP oxidation.  This 
turned out to be true, as cortical MRPs showed no alterations in the degree of oxidation 
across age groups (zero MRPs were >4.0-fold or <0.25-fold oxidized, even in the 18mo 
animals exposed to DNB).  However, brainstem MRPs were sensitive to DNB exposure 
as a function of age:  in 1mo animals, one MRP was significantly less oxidized in 
brainstem (acetyl-CoA acetyltransferase, mitochondrial), which is active in ketone body 
metabolism by mitochondria (27).  This suggests that significantly lower oxidation of this 
enzyme may contribute to the role of ketone metabolism in younger animals and may 
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be part of a protective mitochondrial mechanism in DNB exposure, as no lesions were 
observed in the youngest animals.  Mitochondrial ketone body metabolism provides 
acetyl CoA from acetoacetyl CoA and allows for the production of energy while 
circumventing the need for pyruvate dehydrogenase (28); this may be important in the 
mitochondrial response to DNB exposure, as DNB has been shown to render pyruvate 
dehydrogenase inactive (29).  It must be mentioned that this might only be a significant 
part of the mitochondrial response to DNB in the youngest group of animals and not in 
the 3mo animals, as lesions were not observed in the 3mo group either (and they might 
have a differential mitochondrial response not involving mitochondrial acetyl-CoA 
acetyltransferase).  
There were no changes in brainstem MRP oxidation in 3mo animals, however, in 
18mo animals, 7 MRPs were over 4-fold oxidized by DNB in the brainstem.  Again, 
there were zero changes in cortical MRP oxidation in any age group, which supports the 
previous hypothesis in that even though DNB caused no changes in global MRP 
oxidation, there is regional variation in MRP susceptibility to oxidation.  Additionally, 
within the MRPs that were found to be oxidized by proteomic analysis, brainstem MRPs 
had 3 times the amount of MRPs oxidized >4.0-fold than cortical MRPs.  Furthermore, 
in MRPs that were oxidized >4.0-fold, the average level of oxidation was statistically 
significantly higher in brainstem than in cortex (p<0.05).  This evidence suggests that 
the brainstem mitochondria were indeed more sensitive to oxidation by DNB. 
 There is an aging effect on cortical and brainstem MRP oxidation, with an 
observed >4.0-fold oxidation of 4 MRPs in cortex and 13 MRPs in brainstem compared 
to 1mo cortex and brainstem.  Again, no changes were seen in 3mo cortex or brainstem 
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MRP oxidation.  This gives strong evidence of an age-specific increase in MRP 
oxidation caused by DNB exposure.   
In addition to being region-specific and increased with advanced age of the 
animal, DNB-induced oxidative alterations of MRPs target specific loci within these 
MRPs that constitute specific molecular pathways.  Namely, cation transmembrane 
transporter, nucleoside-triphosphatase, pyrophosphatase, and hydrolase activity 
pathways were all identified as being constituted by significantly oxidized MRPs in the 
brainstem of DNB-exposed animals.  Three MRPs significantly oxidized in brainstem 
constituted four of the five pathways identified in this analysis:  cytoplasmic dynein, 
tubulin, and a plasma membrane calcium-transporting ATPase.  This suggests that a 
mechanistic link between MRP oxidation and the lesions and clinical signs of 
intoxication seen in the oldest animals exposed to DNB may lie in mitochondrial 
transport.  This is supported by evidence in the literature showing that cytoplasmic 
dynein is one of the linker proteins that bind to the microtubule and mitochondrion, and 
along with kinesin-1, facilitates fast transport of the mitochondrion down the microtubule 
in axons (30); the microtubule is composed of a tubulin heterodimer that polymerizes 
and depolymerizes, rendering the microtubule a dynamic component of the 
cytoskeleton.  The plasma membrane calcium-transporting ATPases are responsible for 
the maintenance of intracellular (31) and extracellular (32) calcium concentrations by 
pumping out calcium; aberrant high intracellular calcium concentrations have been 
shown to affect mitochondrial transport in the brain by causing an increase in 
mitochondrial calcium uptake (as is seen in glutamate toxicity (33)), which can cause 
induction of the mitochondrial permeability transition pore (34) and in turn can disrupt 
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the efficiency of mitochondrial trafficking throughout the cell (35).  The potentially 
synergistic effects of the observed DNB-induced oxidation of these three particular 
proteins could significantly disrupt mitochondrial transport in the brainstem of older 
animals, contributing to the observed DNB-induced clinical signs of intoxication in older 
animals.  
While there was observed staining consistent with increased carbonylation in 
neurons in deep cerebellar nuclei in all 3 age groups compared to cortex, there were no 
differences in staining between vehicle control and DNB-exposed animals.  However, 
the asymmetrical perinuclear staining did appear to be more pronounced in the deep 
cerebellar nuclei of 18mo animals.  This suggests that the inclusion of carbonylation as 
part of the mechanism of vulnerability of brainstem nuclei to development of DNB-
induced lesions may be more strongly associated with age than with DNB exposure.  
One must bear in mind that the method of carbonylation detection used in this 
experiment makes no distinction between carbonylated proteins and nucleic acids.   
Furthermore, it detects all carbonylated macromolecules throughout the entire cell, not 
just mitochondrial proteins; mitochondria are a repository for the accumulation of 
irreversible oxidative damage in DNB exposure in the brainstem (Dr. Stephen Steiner, 
unpublished data).  One interpretation of the results obtained is that the pattern of 
staining observed in the perivascular region is that the primary lesion is gliovascular in 
origin, i.e., at the interface of the glial bed and the regional vasculature.  Alternatively, 
perivascular vulnerability may merely be the result of increased oxidation of 
mitochondrial proteins in the neuronal somatic cytoplasm as suggested by more 
intensely stained mitochondria in the cytoplasm.  This experiment provides additional 
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evidence of vacuolation of the neuropil in the deep cerebellar nuclei and vestibular 
nuclei in 18mo DNB exposed rats.  This suggests that the age-related susceptibility to 
lesion development in these nuclei is likely due to astrocytes within those nuclei being 
more susceptible to oxidative stress induced by DNB. 
 One piece of evidence that would have added considerable value to the “aging 
and mitochondrial susceptibility to protein oxidation” paradigm regarding DNB exposure 
is cell-specific MRP oxidation.  There were, however, issues of feasibility regarding 
sufficiency of mitochondrial protein concentration from neurons and astrocytes within 
brainstem loci in which lesions appear in DNB exposure.  Had this been possible, this 
study would have been able to elucidate not only which MRPs are increasingly more 
oxidized during aging in the brainstem, but would have been able to also distinguish 
which MRPs might have been more highly oxidized in astrocytes compared to neurons 
and the resulting pathways that might have differed between the two cell types, thus 
giving a more clear mechanism of injury during DNB intoxication that may be influenced 
by aging.  The hypothesis would have included astrocyte MRPs as more highly oxidized 
compared to neurons in DNB exposure due to evidence pointing to astrocytes as the 
primary cellular target in DNB exposure (14), (36).  As this study stands, however, there 
is clear evidence of a correlation between advanced age, an increase in severity of 
lesions in the brainstem, clinical signs of intoxication, and an increase in MRP oxidation 
in brainstem, which provides important novel data on DNB-induced regional specificity 
of MRP susceptibility to oxidation during aging.     
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Table 3.1.  Conditions and Mortality Rates of Male F344 Rats Sacrificed 24h After Last Exposure.  
Number of animals affected out of total number of animals observed in parentheses.  VC = Vehicle 
Control (DMSO), DNB = 10mg/kg 1,3-Dinitrobenzene given at 0h, 4h, and 24h; sacrificed 24h later.  
These animals were used for mitochondrial isolation and subsequent proteomics experiments.      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Animal 
Age 
Exposure Hunched Ataxia Chromodacryorrhea Mortality 
1mo VC 0% (0/3) 0% (0/3) 0% (0/3) 0% (0/3) 
1mo DNB 0% (0/3) 0% (0/3) 0% (0/3) 0% (0/3) 
3mo VC 0% (0/4) 0% (0/4) 0% (0/4) 0% (0/4) 
3mo DNB 75% (3/4) 25% (1/4) 0% (0/4) 0% (0/4) 
18mo VC 0% (0/3) 0% (0/3) 0% (0/3) 0% (0/3) 
18mo DNB 100% (5/5) 100% (5/5) 100% (5/5) 60% (3/5) 
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Table 3.2. Conditions and Mortality Rates of Male F344 Rats Sacrificed 12h After Last Exposure.  
Number of animals affected out of total number of animals observed in parentheses.  VC = Vehicle 
Control (DMSO), DNB = 10mg/kg 1,3-Dinitrobenzene given at 0h, 4h, and 24h; sacrificed 12h later.  
These animals were used for histopathology experiments.    
 
Animal 
Age 
Exposure Hunched Ataxia Chromodacryorrhea Mortality 
1mo VC 0% (0/6) 0% (0/6) 0% (0/6) 0% (0/6) 
1mo DNB 0% (0/6) 0% (0/6) 0% (0/6) 0% (0/6) 
3mo VC 0% (0/6) 0% (0/6) 0% (0/6) 0% (0/6) 
3mo DNB 0% (0/6) 0% (0/6) 0% (0/6) 0% (0/6) 
18mo VC 0% (0/6) 0% (0/6) 0% (0/6) 0% (0/6) 
18mo DNB 100% (6/6) 100% (6/6) 100% (6/6) 0% (0/6) 
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Figure 3.1. Deep Cerebellar Nuclei in 1mo Male F344 Rats Exposed to DNB 
Hematoxylin and eosin staining of 1mo male F344 rats exposed to DNB (0h, 4h, 24h intraperitoneal 10mg/kg exposure with sacrifice 12h after the 
last exposure) or v/v equivalent of DMSO (VC) on the same time course.  (N=Neuron, V=Vasculature, A with arrow = Astrocyte). Scale bar:  
100um 
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Figure 3.2. Deep Cerebellar Nuclei in 3mo Male F344 Rats Exposed to DNB 
Hematoxylin and eosin staining of 3mo male F344 rats exposed to DNB (0h, 4h, and 24h intraperitoneal 10mg/kg exposure with sacrifice 12h after 
the last exposure) or v/v equivalent of DMSO (VC) on the same time course.  (N=Neuron, V=Vasculature, A with arrow = Astrocyte). Scale bar:  
100um 
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Figure 3.3. Deep Cerebellar Nuclei in 18mo Male F344 Rats Exposed to DNB 
Hematoxylin and eosin staining of 18mo male F344 rats exposed to DNB (0h, 4h, and 24h intraperitoneal 10mg/kg exposure with sacrifice 12h 
after the last exposure) or v/v equivalent of DMSO (VC) on the same time course.  (N=Neuron, V=Vasculature, A with arrow = Astrocyte, Red 
Arrow = Vacuolation). Scale bar:  100um 
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Figure 3.4. Effects of DNB on Global Oxidation of Mitochondria-Related Proteins (MRPs) 
Average fold-change in oxidation of MRPs were calculated as:  %Oxidation values of control brainstem 
divided by %Oxidation values of control cortex (VC) compared to %Oxidation values of DNB-exposed 
brainstem divided by %Oxidation values of DNB-exposed cortex.  Data were uploaded to Prism software 
(Version 5.0, GraphPad) for statistical analysis (student’s t-test).   
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Table 3.3. Effects of DNB on Regional MRP Oxidation 
Identification of MRPs found to be significantly oxidized by DNB (<0.25-fold or >4.0-fold) by calculating %Oxidation 
(=%OxidationDNB/%OxidationVC) for brainstem and cortex within each age group of rats.  Green text denotes >4.0-fold %Oxidation; red text 
denotes <0.25-fold %Oxidation. 
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Table 3.4 Effects of Age on Regional MRP Oxidation 
Identification of MRPs found to be significantly oxidized by DNB (<0.25-fold or >4.0-fold) by calculating %Oxidation 
(=%OxidationDNB/%OxidationVC) for brainstem and cortex as a fold-change of 1mo rats. Green text denotes >4.0-fold %Oxidation. 
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Figure 3.5.  Brainstem and Cortex MRP Oxidation 
Average fold-change in oxidation of MRPs were calculated as:  %Oxidation values of DNB-exposed 
brainstem divided by %Oxidation values of control brainstem (Brainstem) compared to %Oxidation values 
of DNB-exposed cortex divided by %Oxidation values of control cortex (Cortex) (Top).  Percentage of 
oxidized proteins that were oxidized >4-fold were tabulated (Bottom).  Data were uploaded to Prism 
software (Version 5.0, GraphPad) for statistical analysis (student’s t-test).   
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Table 3.5. Pathways Significantly Oxidized by DNB in Brainstem 
UniProtID numbers for proteins <0.25-fold or >4.0-fold oxidized, as determined by %Oxidation, were uploaded to the Database for 
Annotation, Visualization, and Integrated Discovery (DAVID, Nat. Protoc. 2009).  Pathways were identified by selecting GOTerm Molecular 
Function.  Pathways distinct from control brainstem are shown.   
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Figure 3.6.  Carbonylation Detection in 1mo F344 Rats 
2,4-Dinitrophenol staining of 1mo male F344 rats exposed to DNB (0h, 4h, 24h intraperitoneal 10mg/kg exposure with sacrifice 12h after the last 
exposure) or v/v equivalent of DMSO (VC) on the same time course.  (N=Neuron, A with arrow = Astrocyte) Scale bar:  50um 
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Figure 3.7.  Carbonylation Detection in 3mo F344 Rats 
2,4-Dinitrophenol staining of 3mo male F344 rats exposed to DNB (0h, 4h, 24h intraperitoneal 10mg/kg exposure with sacrifice 12h after the last 
exposure) or v/v equivalent of DMSO (VC) on the same time course.  (N=Neuron, A with arrow = Astrocyte) Scale bar:  50um 
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Figure 3.8.  Carbonylation Detection in 18mo F344 Rats 
2,4-Dinitrophenol staining of 18mo male F344 rats exposed to DNB (0h, 4h, 24h intraperitoneal 10mg/kg exposure with sacrifice 12h after the last 
exposure) or v/v equivalent of DMSO (VC) on the same time course.  (N=Neuron, A with arrow = Astrocyte, Red Arrow = Vacuolation). Scale bar:  
50um 
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CHAPTER IV 
 
 
 
Are There Differences in Compensatory Molecular Pathways between Younger 
and Older Brainstem Mitochondria following 1,3-DNB Exposure? 
 
 
INTRODUCTION 
 
 
As mammals age, the ability to efficiently respond to cellular demand for 
adenosine triphosphate (ATP) is generally diminished.  The brain, in particular, has 
extremely high energy demands:  it accounts for only 2% of the body’s mass but 
consumes 20% of the body’s glucose (1).  Thus, age-related deficits or mismatches in 
energy production and utilization can be especially detrimental to mental function.  In a 
study by Dutschke, et al. (1994), aged rats showed significantly lower levels of ATP and 
creatine phosphate in cerebral cortex when subjected to mental activities (passive 
avoidance and hole board tests), compared to younger “mentally active” rats or aged 
rats that weren’t subjected to mental tests (2), suggesting that older rats are less able to 
produce ATP by oxidative phosphorylation in response to metabolic demands in the 
brain.  This is supported by evidence of an age-related decline in cytochrome oxidase 
activity and concurrent increase in mitochondrial size in cerebellar cortex in the aging 
rodent (3), age-related decreases in NADH-cytochrome c reductase activity in whole 
mouse brain (4),and an age-related decrease in mitochondrial electron transfer in whole 
mouse brain (5).   
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Despite supporting evidence that there is an overall decline in mitochondrial 
function in the brain during aging, it’s important to refrain from making generalizations 
regarding age-related changes in mitochondrial function across brain regions:  the 
energetic demands, specific physiological processes, cellular distribution, and spatial 
dynamics differ between and among different brain regions.  Additionally, 
neurodegenerative diseases (of which age is the primary risk factor), including 
Alzheimer’s Disease and Parkinson’s Disease, manifest region-specific mitochondrial 
pathologies (6),(7), indicating that mitochondria within different regions of the brain are 
disparately susceptible to age-related modifications.   
 1,3-Dinitrobenzene (DNB) exposure causes the development of bilaterally 
symmetrical, gliovascular lesions in brainstem nuclei that form the ascending pathway 
of the 8th cranial nerve (8).  DNB exposure results in lesions that target brainstem 
mitochondria, and has been shown to inhibit the pyruvate dehydrogenase complex 
while impairing oxidative energy metabolism (9).  Additionally, mitochondrially-targeted 
effects of DNB include selective carbonylation of mitochondrial proteins in astrocytes 
(10), and induces the opening of the mitochondrial permeability transition pore in 
neurons from brainstem, but not neurons from cortex (11).   
While it is known that DNB exposure causes mitochondrial toxicity in brainstem, 
there was no evidence of how age may alter the susceptibility of brainstem mitochondria 
to DNB.  This study uses a high-throughput proteomics approach to provide novel 
evidence of age-related, DNB-induced, region-specific changes in mitochondria-related 
protein (MRP) expression.  Additionally, this study maps these increases or decreases 
in MRP expression to molecular function pathways, giving insight into which 
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mitochondrial mechanisms in the brainstem are most vulnerable to dysregulation by 
DNB exposure and may have become more susceptible to this type of perturbation due 
to the aging process.        
 
 
MATERIALS AND METHODS 
 
Animals 
 Male F344 rats (1 month old, 3 month old, and 18 month old) were purchased 
from Harlan Laboratories and housed according to University of Michigan’s University 
Committee on Use and Care of Animals policies.  Rats were fed and watered ad libitum 
and housed on a 12-hour light/dark cycle.   
 
Mitochondrial Isolation 
 Rats from each age group were either exposed to 10mg/kg DNB or a v/v 
equivalent of dimethylsulfoxide (DMSO) serving as a vehicle control (at 0h, 4h, and 24h; 
sacrifice occurred 24h after the 24h dose).  Mitochondria were isolated according to the 
protocol (Method C) by Sims & Anderson (12), with minor modifications.  Briefly, the rat 
was anesthetized under isoflurane, decapitated with a small animal guillotine, and the 
brain was rapidly removed.  Brainstem and cortex were dissected from the rest of the 
brain in cold isolation buffer (100mM Tris, 10mM potassium-EDTA, 960mM sucrose, pH 
7.4).  Brainstem and cortex were then weighed and minced in cold isolation buffer.  
Minced tissue was then homogenized using a glass Dounce homogenizer on ice; this 
step was performed while being flushed with argon.  Subsequent centrifugation steps 
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followed.  Prior to the Percoll gradient centrifugation step, digitonin was added to disrupt 
synaptosomal membranes.  Mitochondria were stored at -80°C. 
 
Detection and Identification of Mitochondria-Related Proteins (University of Michigan 
Peptide Synthesis and Proteomics Core and MSBioWorks, LLC, Ann Arbor, MI) 
The volume of each submitted mitochondrial sample was reduced 50% and 20µL of 
the concentrated sample was processed by SDS-PAGE on a 4-12% Bis-Tris Mini-gel 
(Invitrogen) using the MOPS buffer system and non-reducing Laemmli buffer.  Each gel 
lane was excised into ten equal bands and these were processed by in-gel digestion 
using a robot (ProGest, DigiLab): bands were washed with 25mM ammonium 
bicarbonate followed by acetonitrile, reduced with 10mM dithiothreitol at 60°C followed 
by alkylation with 50mM iodoacetamide at room temperature, digested with trypsin 
(Promega) for 4h at 37°C, and quenched with formic acid and the supernatant was 
analyzed directly without further processing.  Samples were then analyzed by 
LC/MS/MS analyzed by nano LC/MS/MS with a Waters NanoAcquity HPLC system 
interfaced to a ThermoFisher Q Exactive mass spectrometer. Peptides were loaded on 
a trapping column and eluted over a 75µm analytical column at 350nL/min; both 
columns were packed with Jupiter Proteo resin (Phenomenex).  The mass spectrometer 
was operated in data-dependent mode, with MS and MS/MS performed at 70,000 and 
17,500 FWHM resolution, respectively. The fifteen most abundant ions were selected 
for MS/MS. Proteins were identified by reference to the UniProt rat database (forward 
and reverse appended with common contaminant proteins) using the Mascot search 
engine. Results were displayed in Scaffold software. 
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Pathway Analysis 
 UniProtID numbers for proteins <0.25-fold or >4.0-fold changed were uploaded to 
the DAVID database (2).  Fold-changes of protein were quantified as the Normalized 
Spectral Abundance Factor (NSAF).  NSAF is calculated by first finding the Spectral 
Abundance Factor: (SAF = Unweighted Spectrum Count/Molecular Weight) and then 
normalizing to the total spectral count for that protein:  (NSAF = SAF/∑Spectral Count).  
Pathways were identified by selecting GOTerm Molecular Function.  Options for 
pathway determination were set to:  3 proteins to constitute a pathway (default setting = 
2), and 0.05 as a significance level for P-values and Benjamini values. 
 
RESULTS 
MRP Normalized Spectral Abundance Factor (NSAF) Fold-Changes in Brainstem 
Brainstem MRPs in young (1mo) control animals are comparatively more 
upregulated (34 proteins) than downregulated (6 proteins) (~6x difference); this does 
not hold true for brainstem MRPs in 1mo rats exposed to DNB (4 upregulated, 7 
downregulated) (Figure 4.1, Tables 4.5 & 4.6).  In 3mo control animals, there were three 
times as many downregulated MRPs (9 proteins) compared to upregulated MRPs (3 
proteins), whereas in 3mo DNB-exposed animals, there were no upregulated MRPs, but 
13 downregulated MRPs (Figure 4.1, Tables 4.7 & 4.8).  In the oldest control animals 
(18mo), there were approximately twice as many downregulated MRPs (12 proteins) as 
there were upregulated MRPs (5 proteins); however, in DNB exposed 18mo animals, 
there were over 5x as many downregulated MRPs (11 proteins) as there were 
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upregulated MRPs (2 proteins) (Figure 4.1, Tables 4.9 & 4.10).  This data suggests that 
there is an age effect on the expression of brainstem MRPs, and that DNB exposure 
exacerbates the increased susceptibility to downregulation of MRP expression in 
brainstem. 
Pathways Significantly Upregulated or Downregulated in Brainstem of Control Rats   
In control animals, 11 molecular function pathways were increased in 1mo 
brainstem (catalytic activity, nucleoside triphosphatase activity, pyrophosphatase 
activity, hydrolase activity, protein binding, ion transmembrane transporter activity, 
protein C-terminus binding, purine ribonucleotide binding, ribonucleotide binding, purine 
nucleotide binding, and nucleotide binding), whereas no pathways were increased in 
brainstem of 3mo and 18mo rats (Table 4.1.)  Conversely, there were no molecular 
function pathways decreased in brainstem of 1mo control rats, whereas catalytic activity 
was decreased in brainstem of 3mo rats and protein binding was decreased in 18mo 
rats (Table 4.1)   
Identification of MRPs in Pathways Significantly Upregulated or Downregulated in 
Brainstem of Control Rats 
Of the 11 pathways upregulated in young control brainstem (Table 4.2), four 
pathways (catalytic activity, nucleoside triphosphatase activity, pyrophosphatase 
activity, and hydrolase activity) contain the same 3 MRPs (ATPase, Ca++ transporting, 
plasma membrane 2; ATPase, Na+/K+ transporting, beta 1 polypeptide; myosin ID); two 
pathways (protein binding, ion transmembrane transporter activity) contain the same 3 
MRPs (ATPase, Ca++ transporting, plasma membrane 2; ATPase, H+ transporting, 
lysosomal V0 ATPase; Na+/K+ transporting polypeptide); and three pathways (purine 
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ribonucleotide, purine nucleotide, and nucleotide binding) contain the same 3 MRPs 
(ATPase, Ca++ transporting, plasma membrane 2; guanine nucleotide binding protein 
(G protein); myosin ID). 
The three MRPs identified as involved in catalytic activity (and downregulated in 
3mo control brainstem) were branched chain ketoacid dehydrogenase E1, aarF domain 
containing kinase 4, and aminoadipate-semialdehyde synthase (Table 4.2).  
Additionally, there were 3 MRPs identified as involved in protein binding and were 
downregulated in 18mo control brainstem:  mitochondrial ribosomal protein S9, 
ferredoxin reductase, and NCK-associated protein 1 (Table 4.2).   
Pathways Significantly Upregulated or Downregulated in Brainstem of DNB-Exposed 
Rats   
In DNB-exposed animals, no pathways were upregulated in brainstem in any of 
the age groups.  However, the same pathway (catalytic activity) was downregulated in 
all 3 age groups (Table 4.3). 
Identification of MRPs in Pathways Significantly Upregulated or Downregulated in 
Brainstem of DNB-Exposed Rats 
Although the same pathway (catalytic activity) was identified as upregulated by 
DNB exposure in brainstem MRPs across the age groups, different proteins were 
identified within this pathway across the age groups (Table 4.4).  In 1mo DNB-exposed 
brainstem, the three MRPs identified in the catalytic activity pathway are as follows:  
DEAH (Asp-Glu-Ala-His) box polypeptide 30, lysyl-tRNA synthetase, and mitochondrial 
translational initiation factor 2 (Table 4.4).  In 3mo DNB-exposed brainstem, the three 
MRPs identified in the catalytic activity pathway are as follows:  sulfite oxidase, malonyl-
CoA decarboxylase, and Cytochrome c oxidase subunit 3 (Table 4.4).  In 18mo DNB-
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exposed brainstem, the three MRPs identified in the catalytic activity pathway are as 
follows:   biphenyl hydrolase-like (serine hydrolase), presenilin 2; chaperone, ABC1 
activity of bc1 complex; and suppressor of var1, 3-like 1 (S. cerevisiae) (Table 4.4).   
 
 
DISCUSSION 
This study provides novel evidence of DNB-induced, region-specific, age-related 
changes in MRP expression.  In general, there is an inverse relationship between age 
and number of upregulated MRPs, with 1mo control animals exhibiting the highest 
number of upregulated MRPs (34 total).  Across control animals, there was also an 
increase in the number of downregulated MRPs as age increased (6 MRPs in 1mo, 9 
MRPs in 3mo, and 12 MRPs in 18mo).  In DNB-exposed animals, however, there was a 
marked decrease in the number of upregulated MRPs, even in the youngest age group 
(7 MRPs in 1mo, 0 MRPs in 3mo, and 2 MRPs in 18mo) while at the same time, there 
was an overall increase in the number of downregulated MRPs as age increased (4 
MRPs in 1mo, 13 MRPs in 3mo, and 11 MRPs in 18mo).  Overall, MRPs are quantified 
at a higher level in 1mo brainstem than older counterparts; this suggests that younger 
animals may be more equipped to appropriately alter metabolic profiles to mitigate the 
toxic effects of DNB.   
This supposition is based on existing evidence supporting an overall decrease in 
brain mitochondrial enzyme expression and activity with advancing age:  in rat brain, 
there’s a decrease in energy metabolizing enzyme activity, including aldolase, citrate 
synthase, and lactate dehydrogenase (of which there’s regional heterogeneity) (13).  In 
85 
 
humans, there is an overall decrease in neural mitochondrial metabolism during the 
healthy aging process (14); this can be exacerbated in cases of neurodegenerative 
disease, such as Alzheimer’s Disease (15), or in instances of exposures to 
environmental neurotoxicants, such as fentrazamide (16) and paraquat (17).   
It is of note that, of the 106 MRPs identified as significantly upregulated or 
downregulated across the age groups, 26 of those (24.5% of the total) were identified 
as an “uncharacterized protein” or “uncharacterized protein fragment”.  This means that 
while they could still be quantified, their function is still unknown.  This presents the 
possibility that the identified MRPs (and pathways identified based on those MRPs) may 
be necessary, but not sufficient, to cause the damage seen in 18mo DNB-exposed 
brainstem. 
Both upregulated and downregulated MRPs were assembled into specific 
pathways based on molecular function.  Since the same three MRPs make up the 
upregulated protein binding and ion transmembrane transporter activity pathways in 
1mo control brainstem, these 3 MRPs could be mechanistically grouped together based 
on their participation in ion homeostasis (ATPase Ca++ transporting, plasma membrane 
2 (18), ATPase H+ transporting, lysosomal V0 ATPase (19), and Na+/K+ transporting 
polypeptide (20)).   
Even though DNB exposure causes downregulation of the same pathway in 
brainstem across the age groups, different MRPs were identified within each; this 
suggests that downregulation of key MRPs during aging may be necessary and/or 
sufficient to cause damage.  This may be especially true of the 18mo animals; the three 
proteins constituting the “catalytic activity” pathway don’t make up a discernable, 
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common mechanistic function (whereas the MRPs in the catalytic activity pathway in 
1mo brainstem can be grouped by transcription of mtDNA and subsequent translation 
(DEAH (Asp-Glu-Ala-His) box polypeptide 30 (21), lysyl-tRNA synthetase (22), and 
mitochondrial translational initiation factor 2 (23)) and 3mo brainstem can be grouped by 
their function in the process of oxidative phosphorylation (sulfite oxidase (24), malonyl-
CoA decarboxylase (25), and cytochrome c oxidase subunit 3 (26)).  Thus, a DNB-
induced decrease in the catalytic activity of biphenyl hydrolase-like serine hydrolase 
presenilin 2 (plays a role in mitochondrial calcium uptake and formation of the 
mitochondrial permeability transition pore (27)), chaperone ABC1 activity of bc1 
complex (necessary for the correct conformation and function of the bc1 complex (28)), 
and suppressor of var1 3-like 1 (S. cerevisiae) (degrades RNA in the presence of ATP 
(29)) in old brainstem, while they don’t functionally intersect, may be necessary to cause 
damage. 
 In summary, DNB causes a decrease in brainstem MRP expression, even in the 
youngest animals.  However, because the youngest control animals exhibited the 
highest endogenous levels of MRPs, this suggests that in comparison to their older 
counterparts they are better equipped to respond to metabolic mitochondrial stressors, 
such as DNB exposure.       
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Figure 4.1. MRP Normalized Spectral Abundance Factor (NSAF) Fold-Changes in Brainstem 
Identification of MRPs found to be significantly changed in brainstem (<0.25-fold or >4.0-fold) by 
calculating NSAF for DNB exposure and controls within each age group of rats.   
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Table 4.1. Pathways Significantly Upregulated or Downregulated in Brainstem of Control Rats  
UniProtID numbers for MRPs <0.25-fold or >4.0-fold changed in control animals, as determined by NSAF, 
were uploaded to the Database for Annotation, Visualization, and Integrated Discovery (2). Pathways 
were identified by selecting GOTerm Molecular Function.   
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Table 4.2. Identification of MRPs in Pathways Significantly Upregulated or Downregulated in 
Brainstem of Control Rats 
UniProtID numbers for MRPs <0.25-fold or >4.0-fold changed in control animals, as determined by NSAF, 
were uploaded to the Database for Annotation, Visualization, and Integrated Discovery (2). Pathways 
were identified by selecting GOTerm Molecular Function.  Pathways were then analyzed for identification 
of MRPs by UniProtID numbers. 
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Table 4.3. Pathways Significantly Upregulated or Downregulated in Brainstem of DNB-Exposed 
Rats  UniProtID numbers for MRPs <0.25-fold or >4.0-fold changed in DNB-exposed animals, as 
determined by NSAF, were uploaded to the Database for Annotation, Visualization, and Integrated 
Discovery (2). Pathways were identified by selecting GOTerm Molecular Function.   
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Table 4.4. Identification of MRPs in Pathways Significantly Upregulated or Downregulated in 
Brainstem of DNB-Exposed Rats 
UniProtID numbers for MRPs <0.25-fold or >4.0-fold changed in DNB-exposed animals, as determined by 
NSAF, were uploaded to the Database for Annotation, Visualization, and Integrated Discovery (2). 
Pathways were identified by selecting GOTerm Molecular Function.  Pathways were then analyzed for 
identification of MRPs by UniProtID numbers. 
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Table 4.5. Fold-Change Values of MRPs Significantly Changed in Brainstem of Control 1mo Rats  
MRPs <0.25-fold or >4.0-fold changed in 1mo control animals, as determined by NSAF.  Green indicates 
>4.0-fold change in NSAF; Red indicates <0.25-fold change in NSAF. 
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Table 4.6. Fold-Change Values of MRPs Significantly Changed in Brainstem of DNB-Exposed 1mo 
Rats  
MRPs <0.25-fold or >4.0-fold changed in 1mo DNB-exposed animals, as determined by NSAF.  Green 
indicates >4.0-fold change in NSAF; Red indicates <0.25-fold change in NSAF. 
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Table 4.7. Fold-Change Values of MRPs Significantly Changed in Brainstem of Control 3mo Rats  
MRPs <0.25-fold or >4.0-fold changed in 3mo control animals, as determined by NSAF.  Green indicates 
>4.0-fold change in NSAF; Red indicates <0.25-fold change in NSAF. 
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Table 4.8. Fold-Change Values of MRPs Significantly Changed in Brainstem of DNB-Exposed 3mo 
Rats  
MRPs <0.25-fold or >4.0-fold changed in 3mo DNB-exposed animals, as determined by NSAF.  Green 
indicates >4.0-fold change in NSAF; Red indicates <0.25-fold change in NSAF. 
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Table 4.9. Fold-Change Values of MRPs Significantly Changed in Brainstem of Control 18mo Rats  
MRPs <0.25-fold or >4.0-fold changed in 18mo control animals, as determined by NSAF.  Green 
indicates >4.0-fold change in NSAF; Red indicates <0.25-fold change in NSAF. 
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Table 4.10. Fold-Change Values of MRPs Significantly Changed in Brainstem of DNB-Exposed 
18mo Rats  
MRPs <0.25-fold or >4.0-fold changed in 18mo DNB-exposed animals, as determined by NSAF.  Green 
indicates >4.0-fold change in NSAF; Red indicates <0.25-fold change in NSAF. 
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CHAPTER V 
 
Conclusion & Future Directions 
 
 The vestibulocochlear nerve (the VIIIth cranial nerve) provides the ascending 
sensory input for the auditory and vestibular systems of the brain, and functions to 
maintain both balance and hearing.  The vestibular and auditory branches of this nerve 
innervate specific brainstem nuclei, including the vestibular nuclei and inferior colliculi 
(1).  Exposure to 1,3-Dinitrobenzene (DNB) causes gliovascular lesions in precisely 
those  regions of the brain supplied by the VIIIth cranial nerve  (2).  Despite the lack of 
any morphological changes in the nerve root (Philbert – unpublished observations), it is 
not clear whether or not the gliovascular lesions produced by DNB in the brainstem are 
the product of primary damage to the nerve per se or direct insult to astrocytes in the 
brainstem: morphological evidence points to the latter.  Nevertheless, auditory function 
and neuronal activity provide insights into the interplay between function and 
susceptibility.  Unilateral rupture of the tympanic membrane reduces glucose 
consumption in vulnerable regions ipsilateral to the deafened ear while exposure of the 
intact ear to white noise exacerbates the lesion in the contralateral brainstem in animals 
that were also exposed to DNB (3).  These findings provide compelling evidence that 
that metabolic demand (and, therefore, mitochondrial workload) in response to the level 
of auditory function and lesion severity are closely interrelated. 
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  Astrocytes provide structural collateral stabilization to neurons, trophic 
biochemical support, participate in regulatory volume decrease through the 
management of ions in the extracellular space and actively maintain the integrity of the 
blood-brain-barrier:  all functions that require energy and, by extension, functional 
mitochondria (4).  Astrocytes are a primary cellular target of DNB as indicated by the 
rapid onset of focal oncotic necrosis observed in vulnerable brainstem nuclei adjacent to 
the IVth ventricle prior to neuronal involvement (2).  One important way in which 
astrocytes protect neurons is by releasing adenosine triphosphate (ATP) into the 
extracellular space, which is dephosphorylated to adenosine which itself binds to the A1 
receptor on the neuronal surface and attenuates synaptic transmission (5).  An increase 
in extracellular adenosine has been shown to occur rapidly in a concentration-
dependent fashion following exposure of DI-TNC1 immortalized astrocytes to DNB in 
vitro (6).  This finding in vitro is consistent with the idea adenosine is either passively 
(through loss of membrane integrity) or actively (through as yet unidentified membrane 
transport mechanisms) released by astrocytes into the extracellular space where it may 
act as a silencing neurotransmitter on neuronal adenosine receptors following DNB 
exposure.  The functional consequence of this sequence of events us that DNB 
exposure causes ataxia in rats due to development of lesions in the vestibular system 
(2).   
 While DNB exposure causes diminution of proprioception that manifests as ataxia, 
the physiological aging process provides for time-dependent degradation of 
audiovestibular function:  in humans, increased age is associated with increased 
numbers of amyloid plaque in the vestibulocochlear nerve (mainly confined to the glia) 
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(7).  Epidemiological studies support the link between age-related loss of function of the 
sensory pathways of the vestibulocochlear nerve:  sixty-three percent of people in the 
United States over the age of 70 have hearing loss (8), and 40% of people over the age 
of 65 living in the United States living at home will fall at least once per year, with 75% 
of deaths due to falls occurring in this age group (9).  Additionally, a recent study 
investigated the link between incidence of falls and hearing loss in older adults in the 
United States, and found that the transition from normal hearing to mild hearing loss is 
associated with a 3-fold increased odds of reporting a fall within the last year (10). 
These clinical and epidemiological findings in humans are supported by experimental 
studies in rodents. 
 Older mice exhibit higher levels of oxidized mitochondrial glutathione and mtDNA 
in the brain compared to younger mice, which was found to be inversely related with 
motor coordination in the older mice (11).  These data suggest that age-related loss of 
function of the vestibular and auditory systems may be linked, and may be a result of 
mitochondrial and glial dysfunction manifesting over time.  This attenuation of function 
during the aging process was hypothesized to increase mitochondrial susceptibility in 
the brainstem to DNB-induced neurotoxicity; this overarching hypothesis was tested 
using in vitro methods investigating neuroprotective functions of astrocytes exposed to 
DNB as a function of passage number, and in vivo methods investigating the role of 
aging in regionally differential mitochondrial susceptibility to protein oxidation and 
differential MRP expression in DNB exposure.  
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PASSAGE EFFECT IN ASTROCYTES – SURROGATE FOR AGING 
 Astrocytes provide neuronal support by composing the blood brain barrier and 
releasing neuroprotective factors such as adenosine; DNB exposure causes breakdown 
of the former (observed as astrocytic foot process swelling) (2) and induction of the 
latter (6).  Despite their responsibility to maintain the neuronal extracellular environment, 
astrocytes in the aging brain lose their ability to perform neuroprotective functions, 
including maintenance of neuronal mitochondrial membrane potential (12). 
 While immortalized cells are used in laboratories because of their relative ease 
and reproducibility of results regardless of how many times they are passaged, this 
study provides novel data on DNB-induced functional changes in high passage 
immortalized astrocytes (DI-TNC1) compared to low passage immortalized astrocytes.  
Metrics of mitochondrial function were assessed in monoculture DI-TNC1 astrocytes and 
in DI-TNC1 astrocytes co-cultured with primary neurons, as were neuroprotective 
functions. 
 Monoculture high passage DI-TNC1 astrocytes contain mitochondria that are 
more sensitive to DNB exposure than low passage DI-TNC1 astrocytes; there was an 
observed passage#-dependent susceptibility to first mitochondrial flickering events and 
a concurrent decrease in mitochondrial aspect ratio in which high passage DI-TNC1 
astrocytes exhibit an earlier first flickering event and decrease in mitochondrial aspect 
ratio compared to low passage DI-TNC1 astrocytes.  Based on mitochondrial dynamics 
in monoculture DI-TNC1 astrocytes, the described passage effect may be an acceptable 
surrogate for the aging of astroctyes in vitro, as these same mitochondrial dynamics are 
altered significantly in the aged brain (mitochondrial volume increase in aged rat brain 
(13), decreased mitochondrial membrane potential in senescence-accelerated mice 
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prone (SAMP8) mouse astrocytes (14).  These measurements of mitochondrial 
dynamics correlate with an attenuation of high passage DI-TNC1 astrocyte proliferation 
compared to low passage DI-TNC1 astrocyte proliferation, suggesting that the observed 
disturbances in mitochondrial dynamics in high passage DI-TNC1 astrocytes are 
reflective of decreased mitochondrial function, as cellular proliferation is an “energy-
expensive” process.   
 In a co-culture system, high passage DI-TNC1 astrocytes exhibited less effective 
neuroprotective functions than low passage DI-TNC1 astrocytes.  This was evident in 
data presented in Chapter II in which low passage DI-TNC1 astrocytes prevented 
neuronal depolarization to a greater extent than high passage DI-TNC1 astrocytes in 
DNB exposure and prevented mitochondrial depolarization in neurons to a greater 
extent than high passage DI-TNC1 astrocytes in DNB exposure.  Furthermore, low 
passage DI-TNC1 astrocytes were better able to survive DNB exposure in a co-culture 
system, which suggests that not only do mitochondria from low passage DI-TNC1 
astrocytes have the ability to function such that they preserve astrocytic functions in 
response to the neuronal environment, but also maintain astrocyte viability in DNB 
exposure.  This level of resistance to DNB exposure was not observed in high passage 
DI-TNC1 astrocytes.        
 This study provides compelling evidence supporting a mitochondrial role in the 
passage effect observed in astrocytes in DNB exposure indicating that the observed 
changes are necessary for DNB-induced neurotoxicity.  However, the data in this aim 
do not assume sufficiency to cause lesions as observed in DNB exposure.  
Neurotoxicity caused by DNB involves multiple factors, some of which have already 
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been elucidated in astrocytes:  adenosine release by DI-TNC1 astrocytes (6) and 
carbonylation of specific mitochondrial proteins in DI-TNC1 astrocytes (15).  Due to the 
regionally-specific nature of lesions induced by DNB exposure, the current aim ignores 
any inherent, physiological differences there might be between brainstem astrocytes 
and other astrocytes; since DI-TNC1 astrocytes are derived from diencephalon, which 
doesn’t incur lesions in DNB exposure, this aim may be overlooking some of these as of 
yet unknown, potentially functional differences in astrocytes from different regions of the 
brain.  However, this study adds to the current body of data utilizing DI-TNC1 astrocytes 
to investigate cell-specific changes in DNB exposure in that it investigates the role of 
aging by way of passage number as a proxy for the aging process.   
To further elucidate mitochondrial mechanisms that may be affected by passage 
number in DNB exposure, the co-culture experiments investigating intracellular calcium 
dynamics in neurons may be expanded.  The current data shows that DNB exposure 
causes a decrease in free cytosolic calcium in neurons co-cultured with both low and 
high DI-TNC1 astrocytes, with the low passage DI-TNC1 astrocytes exhibiting more 
pronounced prevention of depolarization (as measured by free intracellular calcium 
concentrations).  Because mitochondria are a storage compartment for intracellular 
calcium in neurons (16) and the ability of mitochondria to buffer the intracellular space 
by sequestering calcium diminishes in the aging brain (17), it’s possible that neurons co-
cultured with low passage DI-TNC1 astrocytes mimics a “younger” phenotype in which 
the observed lower intracellular calcium concentration in neurons caused by DNB 
exposure compared to neurons co-cultured with high passage DI-TNC1 astrocytes is 
due to an increase in mitochondrial calcium sequestration.  This could be determined by 
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utilizing a mitochondrially-permeant, calcium-indicating dye (such as Rhod2 AM) 
concurrently with a dye that fluoresces upon binding with free cytosolic calcium (such as 
Fluo4 AM) and time-lapse fluorescence imaging as performed in Chapter II.  
 Future work aiming to determine whether or not high passage DI-TNC1 
astrocytes are an acceptable proxy for aged astrocytes in vivo could include a 
proteomic analysis of methionine oxidation and MRP expression in isolated 
mitochondria from both low passage DI-TNC1 astrocytes and high passage DI-TNC1 
astrocytes.  This would provide a direct contrast with data presented in Chapters III & IV 
of this dissertation, and place the observed in vivo data from those two chapters further 
in context with the metrics of neuroprotection observed in Chapter II.   
 
AGE-ASSOCIATED, DNB-INDUCED SPECIFIC OXIDATIVE PROTEOMIC 
MODIFICATIONS IN BRAINSTEM MITOCHONDRIA  
 While it is generally true that the brain becomes more oxidized with age, the type 
of macromolecule that’s targeted for oxidation and the degree to which oxidation occurs 
on these macromolecules can vary by region (18), (19), (20).  In this study, not only 
were brainstem MRPs more prone to DNB-induced oxidation than cortical MRPs, the 
degree to which the oxidation occurred in brainstem MRPs was significantly higher than 
their cortical counterparts.  This suggests that there is regional variation in susceptibility 
to DNB-induced MRP oxidation, and that increased oxidation to MRPs in aggregate 
may be part of the mechanism of injury in the development of lesions in the brainstem 
due to DNB exposure.  However, Chapter III provides convincing evidence that the 
sheer amount of oxidation incurred by the mitochondrial proteome during aging which 
becomes exacerbated by DNB exposure might not fully explain lesion development; 
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there is clear specificity with which DNB-induced oxidation occurs.  This is true with 
regards to both region (in 1mo animals, there is a decrease in oxidation in one MRP in 
brainstem, no changes observed in 3mo animals, and an increase in oxidation in 7 
MRPs in 18mo brainstem; no decreases below 0.25-fold or increases above 4.0-fold in 
%Oxidation were observed in cortex) and age (there was an observed >4.0-fold 
oxidation of 4 MRPs in cortex and 13 MRPs in brainstem compared to 1mo cortex and 
brainstem, and no changes were seen in 3mo cortex or brainstem MRP oxidation). 
 Age was associated with the development of DNB-induced lesions; only in the 
brainstem of the oldest animals was there an observed vacuolation pattern typical of 
DNB exposure (2) and consistent with the swelling of astrocyte processes (21).  There 
must be careful interpretation of this data when using the observed MRP oxidation data 
to explain the mechanism behind lesion development:  the mitochondria used in the 
proteomics experiment were isolated from animals exposed to DNB at 0h, 4h, and 24h 
with a 24h lapse between the last exposure and animal sacrifice; this exposure timeline 
was only used for the mitochondrial isolation experiments due to the high mortality rate 
in the oldest group of DNB-exposed animals (60%).  For this purpose, we used the 
following exposure timeline for the remaining experiments (hematoxylin and eosin-
stained sections for lesion analysis; immunohistochemistry for presence of 
carbonylation):  0h, 4h, and 24h with a 12h lapse between the last exposure and animal 
sacrifice.  That said, it is likely that the specificity and amount of MRP oxidation 
observed would be attributed to a more severe pattern of lesion in brainstem of the 
oldest DNB-exposed animals, as the development of lesions in the brainstem of the 
oldest DNB-exposed animals was still observed in a shorter exposure timeline.  
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Additionally, in each group of exposure timelines, the oldest animals exposed to DNB 
presented with ataxia at a rate of 100%. 
In addition to causing widespread oxidation in brainstem MRPs, DNB also 
causes specific oxidation in brainstem MRPs that constitute distinct molecular 
pathways:  cation transmembrane transporter, nucleoside-triphosphatase, 
pyrophosphatase, and hydrolase activity.  The same three MRPs constituted 80% of the 
pathways identified as significantly oxidized in brainstem by DNB:  cytoplasmic dynein, 
tubulin, and a plasma membrane calcium-transporting ATPase.  All three of these 
proteins are involved in mitochondrial transport:  dynein is one of the linker proteins that 
binds to both the mitochondrion and the microtubule, facilitating mitochondrial transport 
in neurons (22), tubulin heterodimers form the microtubule on which the mitochondrion 
is transported throughout the cell, and calcium-transporting ATPases regulate 
intracellular and extracellular calcium levels; if intracellular calcium concentrations are 
elevated in the brain, the induction of the mitochondrial permeability transition pore may 
occur (23), which can alter the pattern of mitochondrial transport throughout the cell 
(24).  Because cytoplasmic dynein, tubulin, and calcium-transporting ATPases 
participate in mitochondrial transport, it’s plausible that part of the mechanism of DNB 
neurotoxicity in the brainstem related to advanced age results from the inability of the 
neural cells in this region to respond to localized demand for ATP.  This is supported by 
evidence showing that in rodents presenting with neurodegenerative pathologies, 
mitochondrial trafficking in the brain is diminished (25).   A resulting hypothesis might 
be, then, that the observed DNB-induced oxidation to dynein, tubulin, and calcium-
transporting ATPases in the brainstem may result in functional changes to those 
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proteins, providing a mechanistic basis for the observed lesions and clinical signs of 
intoxication in the oldest animals exposed to DNB.  Relevant future experiments would 
include conducting activity assays on these proteins purified from the brainstem of old 
animals exposed to DNB.  
 Because DNB targets brainstem astrocytes prior to the appearance of neuronal 
effects (2), future work might include the proteomic analysis of cell-specific oxidative 
modifications to MRPs in brainstem.  For the purposes of this study, the lack of 
sufficiency of protein concentrations from each respective cell type in affected regions of 
the brainstem prevented a proteomic analysis of this type.  Because there are 
significant age-associated increases in both neuron (26), (27) and astrocyte oxidation 
(28), (29) in the brain, it is likely that there will be significant increases oxidation in each 
cell type in old animals; however, due to astrocytes being a cellular target of DNB, it 
could be hypothesized that astrocytes would likely accrue more oxidative damage than 
neurons in the brainstem in DNB exposure, even in the oldest animals. 
 
MITOCHONDRIA-RELATED PROTEIN EXPRESSION AS A FUNCTION OF AGE, 
BRAIN REGION, AND DNB EXPOSURE 
 In this study, increased expression of MRPs in young control brainstem 
correlates with resistance against lesion development in the brainstem and presentation 
of clinical signs of intoxication during DNB exposure.  This suggests that younger 
animals have compensatory molecular pathways in the brainstem that aid in the 
response to DNB-induced neurotoxicity, which was indeed shown to be true in Chapter 
IV.  In young control animals, there were 11 distinct molecular function pathways 
upregulated in the brainstem, whereas there were no upregulated pathways in either 
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3mo or 18mo brainstem.  In fact, catalytic activity was downregulated in 3mo brainstem 
and protein binding was decreased in the 18mo brainstem in control animals, 
suggesting that the physiological aging process itself causes a decrease in cohesive 
pathways involving MRPs.  Interestingly, DNB exposure caused the downregulation of 
the same pathway in the brainstem of every age group (catalytic activity).  However, the 
proteins that constituted the catalytic activity pathway were different for each age group.  
This suggests that while DNB exposure causes a decrease in very specific MRPs in the 
brainstem that participate in catalysis, the reactions which require catalysis by these 
MRPs are targeted differentially by DNB in an age-dependent manner.  That is, the 
observed downregulation in brainstem MRPs induced by DNB may be made more 
susceptible due to the physiological aging process.            
While the observed changes in MRP expression appear to be necessary to 
confer age-related mitochondrial susceptibility to DNB-induced neurotoxicity, it has not 
been determined sufficient to describe aging effects on this relationship in totality.  It is 
indeed true that young control animals display increased expression of MRPs compared 
to older control animals and that DNB exposure drastically decreases MRP expression 
compared to each respective age-matched control.  However, there are factors affecting 
protein expression itself that are of particular importance to mitochondrial proteins in the 
aging brain.  Because mtDNA only contains 37 genes, 13 of which contain the genes for 
enzymes in the electron transport chain, the majority of MRPs are expressed by nuclear 
genes (nuclear genes encode 99% of mitochondrial proteins; 1% are encoded by 
mtDNA) (30).  In order for a protein to be imported into the mitochondrion for use, it 
must contain a targeting signal to be recognized by the mitochondrion and must be in 
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the proper conformation (30), as most mitochondrially-imported proteins are kept in an 
unfolded conformation prior to import (31).  Aging is known to decrease the efficiency of 
this process:  protein misfolding increases in the brain during aging (32), and increased 
oxidative stress (as is often associated with increases in age) inhibits the protein import 
into mitochondria (33).   
Additionally, DNB exposure causes the selective carbonylation of mitochondrial 
heat shock protein 70 (mtHsp70) in astrocytes (15).  Because mtHsp70 is a molecular 
chaperone that uses ATP to translocate mitochondrially-targeted polypeptides from the 
cytosol to the mitochondrial matrix (34), the decrease in MRP expression caused by 
DNB even in the youngest age group could be related to dysregulation of brainstem 
MRP import and processing in astrocytes; the loss of regulation of protein folding itself 
during aging in the brain likely exacerbated the effects of DNB in the oldest animals.  
Because many MRPs first exist as “precursor peptides” (31) that can easily 
become misfolded, recent work has shown that mitochondria may be able to more 
efficiently respond to localized demands for ATP by maintaining higher amounts of 
mRNA for mitochondrially-tagged proteins in a close vicinity to the mitochondrion 
[Reviewed by Devaux, et al. (35)].  This suggests that levels of mRNA specific to MRPs, 
not just MRP expression itself, may be very important to the ability of the mitochondrion 
to respond to localized ATP demands, which is likely diminished in aged animals 
exposed to DNB.      
 Future work investigating the role of aging and DNB exposure on proper MRP 
import and processing would involve procuring the cytosolic fraction of proteins in 
addition to the mitochondrial fraction to compare the concentrations of mitochondrially-
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tagged peptides destined for the mitochondrion versus those that actually gain entry to 
the organelle.  This experiment could be done using the same LC/MS-MS techniques 
used in this study.  Additionally, to assess for proper protein folding, one could use the 
results generated from the LC/MS/MS to compile a list of MRPs of interest, purify the 
protein, and assess for secondary protein structure by using circular dichroism or 
protein nuclear magnetic resonance.   
ADDITIONAL CONSIDERATIONS 
Sex-Specific Differences in Neural Function across the Lifespan – Relevance to Current 
Study 
 This study utilized only male rats for the investigation of aging effects on 
mitochondrial susceptibility to DNB-induced neurotoxicity.  Therefore, these results may 
not be as easily extended to include the total population.  That said, the experimental 
design excluded female rats for reasons of simplicity:  estrogen acts as a 
neuroprotective hormone in cases of stroke [reviewed by Liu and Yang (36)], 
Parkinson’s Disease [(reviewed by Bourque (37)], and Alzheimer’s Disease [reviewed 
by Correia (38)].  While male rodents do express estrogen receptors in the brain (39), 
females typically have higher and more variable circulating concentrations of estrogen 
compared to males (40).  Therefore, estrogenic effects on endpoints measured in this 
study could have potentially masked or exaggerated the results, as the concentration of 
estrogen fluctuates with the animal’s age (40).   
Because of the potentially confounding role of estrogen in its ability to be 
neuroprotective, it would likely introduce a differential response to DNB between male 
and female rats.  This supposition is reinforced by a body of recent evidence suggesting 
that astrocytes are involved with estrogenic neuroprotective pathways in response to 
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manganese exposure (41), in Alzheimer’s Disease (42), and in 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine (MPTP) exposure in male mice (43).  Because astrocytes are 
a primary cellular target in DNB exposure (2), the pathophysiological mechanisms with 
which male and female rodents respond to DNB may differ.  Additionally, estrogen can 
interact directly with mitochondria by binding directly to Complex V of the electron 
transport chain, causing inhibition of this complex (44).  Therefore, not only does 
estrogen interact with the cellular target of DNB, but also with an important organellar 
target of DNB, the mitochondrion, further establishing sex-specific differences related to 
estrogen as a potential confounder. 
Moreover, there is evidence supporting age-related, sex-specific differences in 
mitochondrial function in the aging rodent brain (in which females retain mitochondria 
that are more functional than mitochondria in males) (45), which may or may not have 
anything to do with estrogen itself.  In the human brain, men exhibit age-related 
decreases in whole brain and frontal and temporal lobe volume, whereas in women, 
significant age-related losses in volume occur in the parietal lobes and hippocampus 
(46).  The same study also found sex-specific differential glucose metabolism that 
varied across regions of the brain (46). 
 Because there are as of yet undetermined mechanisms underlying neurotoxic 
effects of environmental exposures, this study may be excluding important factors in the 
female brain that confer mitochondrial susceptibility to neurotoxicity.  The most obvious 
oversight may be in the aforementioned role of estrogen in neuroprotection.  However, 
there are more overlapping neural mechanisms between the male and female brain 
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than not; thus, this study still highlights important insight into the role of aging on 
mitochondrial susceptibility to DNB toxicity.     
 
CONCLUDING REMARKS 
 This body of work gives supporting evidence of age-related mitochondrial 
susceptibility to DNB-induced neurotoxicity.  Because both in vivo and in vitro methods 
were utilized in this study, it provides not only an in-depth look at the neuroprotective 
capacity of astrocytes due to their age in vitro, but also gain insight into specific 
mitochondrial posttranslational modifications as a result of aging and induced by DNB 
exposure in vivo, which gives a more inclusive picture of physiological aging compared 
to what is offered by in vitro techniques. 
 This study highlights the intersection between mitochondrial insults that may 
accrue during the lifespan and additional mitochondrial stress induced by exposure to 
DNB.  Data put forth in this dissertation supports the hypotheses that astrocytes are 
less able to perform neuroprotective functions as they age, that DNB exposure causes 
age-related, region-specific, significant oxidative damage to MRPs, and that DNB 
exposure causes an age-related, region-specific decrease in MRP expression.  These 
results indicate that the observed age-related alterations to astrocyte mitochondrial 
dynamics and resultant neuroprotective functions, and specific damage to brainstem 
MRPs as a result of DNB exposure are necessary to produce lesions and manifest as 
ataxia.  There are, however, other components of the mechanism by which DNB 
induces damage to the brainstem with a resultant loss of function of the vestibular and 
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auditory system:  adenosine release by astrocytes (6), carbonylation of specific MRPs in 
astrocytes (15), increased cerebral blood flow (47), decreases of glutathione concurrent 
with increases in glucose consumption in astrocytes (48), and region-specific alterations 
to astrocyte mitochondrial membrane potential (49).  Thus, the data presented in this 
study is novel in that it includes an aging component in mitochondrial susceptibility to 
DNB neurotoxicity (and is necessary to induce injury), but alone is not sufficient to 
explain the mechanisms involved in DNB neurotoxicity. 
While DNB is known to cause gliovascular lesions confined to specific brainstem 
nuclei (2) which cause ataxia due to loss of function in the vestibulocochlear system, 
there is an age-related decrease in the function of the vestibulocochlear system as well, 
as evidenced by the increased incidence of falls and loss of hearing in the elderly 
population in the United States (8), (9).  The physiological aging process induces 
vulnerabilities, such as an overall increase in mitochondrial oxidative stress, the blood-
brain barrier becomes leaky, and astrocyte function declines.  These functional declines 
are not confined to those areas in which DNB exposure causes lesions, but instead 
have been observed globally in the brain.  In either DNB exposure or aging, decreases 
in function in the vestibular and auditory systems are typically not sufficient to cause 
death; rather, the morphological alterations are precipitating events in the progression 
toward an increased risk of mortality/morbidity (9). 
The question still remains, then, what renders brainstem astrocytes and mitochondria 
more vulnerable to DNB-induced damage (a condition that is exacerbated by the aging 
process); conversely, what makes cortical astrocyte mitochondria more resistant to this 
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age-related susceptibility to damage caused by DNB exposure remains to be 
investigated.   
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